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Summary 
Some sequences of DNA that possess certain guanine or cytosine-riched 
stretches are capable of associating into two types of four-stranded DNA structures, 
namely G-quadruplex and i-motif respectively. It has been suggested in the past that 
some of these quadruplex structures could exist in some biologically important 
regions of DNA such as at the end of chromosomes and in the regulatory regions of 
oncogenes. In addition, due to their distinctive structural characteristics, quadruplex 
structures of DNA have been widely used as building blocks in various 
nanotechnological applications, such as G-quadruplex nanodevices and i-motif 
nanoswitches. With the aim of exploring new properties and applications of 
quadruplex DNA during my graduate studies, we have (1) constructed i-motif DNA-
based molecular devices that are operable through variations of their surrounding pH 
values; (2) developed certain fluorescence-tagged circular G-quadruplexes to be used 
as molecular probes; and (3) investigated the factors that affect the G-quadruplex that 
could undergo self-cleavage reactions. Finally, we have designed and synthesized 
certain dumbbell-shaped oligonucleotides and further examined their inhibitory 
effects on the activities of human topoisomerase I.  
In Chapter 2, design and synthesis of a novel quadruplex DNA machine is 
presented that was capable of converting chemical energy into elastic potential 
energy. As a consequence of this energy converting process, Watson-Crick hydrogen 
bonding interaction between two complementary 11-mer oligonucleotides was forced 
to break down, leading to a free energy change of 12.46 kcal mol-1.   
In Chapter 3, self-cleavage reaction of a guanine-riched oligonucleotide was 
thoroughly studied during our investigation. Subsequent examinations on certain 
factors that affect self-cleavage reactions of G-quadruplexes are described, such as 
 ix
variation of metal ions, pH values and concentration of DNA. In addition, kinetic 
analysis of self-cleavage of G-quadruplex was also carried out. It is our hope that the 
results reported in this chapter could be helpful for searching for new G-quadruplex 
structures that could perform self-cleavage reactions. 
In Chapter 4, our studies of synthesis and characterization of unimolecularly 
circular G-quadruplex on the template basis of G-quadruplex through chemical 
ligations of guanine-riched oligonucleotides are described. Loop-size effect of ligation 
reaction, conformation dependence of circularization course, effects of alkali ions and 
pH values as well as concentration of potassium ions on the circularization reactions 
were investigated during our studies. The potential application of the obtained 
unimolecularly circular G-quadruplex in certain biological processes is also presented 
in this chapter. 
In Chapter 5, design and synthesis of a series of dumbbell-shaped circular 
oligonucleotides containing internal C3-spacers are presented. Our studies 
demonstrated that this C3-spacer-containing oligonucleotide displays an IC50 value of 
33 nM in its inhibition on the activity of human topoisomerase I, which is much 
efficient than those of camptothecins (anticancer drugs currently in clinical use). 
 x
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1.1 Basic Information about DNA 
Deoxyribonucleic acid (DNA) is a type of biomacromolecule that contains 
genetic information used for the functioning of living organisms.1 The major role of 
DNA in vivo is its long-term storage of genetic information. From the perspective of 
chemistry, DNA is a long polymer built up on simple units called nucleotides, linked 
together through a backbone made of sugars and phosphate groups.1, 2 A single strand 
form of DNA is a long chain composed of different nucleotides. Each nucleotide 
consists of a sugar, a phosphate and a nitrogenous base. There are four different types 
of bases in DNA (Figure 1-1), and each base is usually abbreviated by the first letter 
of its name: Adenine (A), Thymine (T), Guanine (G) and Cytosine(C). Two strands of 
nucleotides usually wrap around each other, which are twisted together into a long 
helix; like a ladder twisted about its long axis (Figure 1-2).2 The backbone of sugar-
phosphate linkages forms the uprights of the twisted ladder. The rungs of the ladder 
are made up of base pairs, which are almost always found connected to each other. 
Each twist of the ladder contains approximately 10 rungs, which is 0.34 nm apart. In a 
complete helix, A always lines up with T and G goes with C. In these combinations, 
the different bases fit together perfectly like a lock and key, which is termed with 
“Watson-Crick base pairing” (Figure 1-2).2 
 2
Adenine - A Cytosine - C
Guanine - GThymine - T
 











Figure 1-2. Base Pairing in DNA Double Helix 
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1.2 G-Quadruplex Form of DNA 
1.2.1 Guanine Quartets  
DNA commonly exists in the form of duplex structure in which two self-
complementary strands are held together by Watson–Crick base pairs. Besides this 
form of duplex DNA, certain guanine-riched DNA sequences can form four-stranded 
structures, namely G-quadruplexes.3-6 The basic building block of G-quadruplex is the 
guanine quartets (also known as guanine tetrads) composed of four guanine bases 
arrayed in a square planar configuration, in which each base is both the donor and 
acceptor of two hydrogen bonds with its neighbors (Figure 1-3). More precisely, the 
guanine quartet arises from the association of four guanines into a cyclic Hoogsteen 
hydrogen bonding arrangement that involves N1, N7, O6 and N2 of each guanine 
base. 7-10 Positively charged metal ions can be sandwiched between the quartets. Their 
presence in the central cavity of the quadruplex helps maintain the stability of the 
tetraplex structure.3 In addition, the G-quartet could form a particularly effective 
stacking unit when placed next to each other, resulting in a strong attraction that 






































Figure 1-3.  Structures of Guanine Quartets 
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1.2.2 G-quadruplexes 
In certain guanine-riched strands, two or more G-quartets can stack upon each 
other to form four-stranded structures with a guanine tetrad core. These structures are 
known as G-quadruplexes.3 The term G-quadruplex refers to any four-stranded DNA 
structure containing guanine quartets without reference to strand connectivity. 3-5 
G-quadruplexes exhibit an unusual dependence on specific metal ions, usually 
K+ and occasionally Na+,20 which results in very tight metal binding via inner sphere 
coordination. The cavity between G-quartets is well suited to coordinating the right 
size of cations because the two planes of quartets are lined by eight carboxyl O6 
atoms from guanine. It was reported that a wide variety of cations are capable of 
occupying the central cavity of quadruplex structures, including monovalent ions such 
as NH4+ and Tl+ and divalent cations such as Sr2+, Ba2+, and Pb2+.21 
1.2.2.1 Discovery of G-quadruplex DNA 
It was known since early 19th century that guanosine and its derivatives could 
form viscous gels in water.22 Until 1962, David R. Davies et. al.23 proposed on  the 
basis of X-ray diffraction data that four guanine bases form a planar structure through 
Hoogsteen hydrogen bonding interaction.22 Subsequent NMR studies of these gels 
further suggested that cations such as Na+ and K+ could coordinate to the O6 atoms of 
each guanine base and strongly influence the specific type of structure adopted by the 
gels.24 
1.2.2.2 Structural Polymorphism of G-quadruplex Structures 
One of the most intriguing aspects of G-quadruplex is their extensive 
polymorphism which arises from variation of strand stoichiometry, strand polarity and 
connecting loop.11-15 Quadruplexes typically contain 1, 2, or 4 nucleic acid strands, 
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giving rise to unimolecular, bimolecular or four-stranded structures and display a 
wide variety of topologies (Figure 1-4). These tetraplex structures can exist in 
different isomeric forms caused by different strand polarities of adjacent backbones. 
Certain guanine-riched sequences can, for example, orient themselves in all parallel, 
three parallel and one anti-parallel, adjacent parallel or alternating anti-parallel.10 























































Figure 1-4. G-quadruplex structures formed from one, two or four strands 
1.2.2.2.1 Strand Stoichiometry  
G-quadruplexes could be formed by association of one (Figure 1-5A), two 
(Figure 1-5B), or four strands (Figure 1-5C) of oligonucleotides. The structural 
assemblies of unimolecular, biomolecular and tetramolecular G-quadruplexes could 
display different physical and chemical properties.  
 
Figure 1-5.  Stoichiometries of G-Quadruplex structures 
1.2.2.2.2 Strand Polarity Polymorphism 
The additional structural characteristic of G-quadruplex is the relative 
arrangement of adjacent backbones, which could have different polarities. The four 
 6
strands of oligonucleotides in a G-quadruplex can be all parallel (Figure 1-6A), three 
parallel and one anti-parallel (Figure 1-6B), adjacent parallel (Figure 1-6C), or 
alternating anti-parallel (Figure 1-6D). Many guanine-riched oligonucleotides have 
been determined either with NMR26 or crystallography27, which displayed different 
strand polarities as shown in Figure 1-6. 
 
Figure 1-6.  Different strand polarity arrangements of G-quadruplexes 
1.2.2.2.3 Connecting Loops 
The loops that connect guanine quartets participating in the formation of 
unimolecular or bimolecular G-quadruplexes can run in different ways. The two 
strands involved in bimolecular G-quadruplexes can have loops that connect guanine 
tracts either diagonally or edgewise. 25 
 
Figure 1-7.  Strand connectivity alternatives for bimolecular guanine tetrad structures 
Diagonal loops are expected to protrude on opposite ends of the guanine tetrad 
core (Figure 1-7A). When the two loops connect guanine tracts edgewise, they can be 
either on the same or on opposite sides of the tetrad core. Loops on the same side of 
the core can be either parallel (Figure 1-7B) or anti-parallel (Figure 1-7C). When the 
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two loops protrude on opposite sides of the core, they can run in two different 
directions (Figure 1-7D and 1-7E).  
For unimolecular G-quadruplexes, structural isomers of G-quadruplex caused 
by loop-connecting fashion are fewer. In order to avoid the clash of two diagonal 
loops on the same side, the three loops can join either in the order adjacent-adjacent-
adjacent (Figure 1-8A) or adjacent- diagonal-adjacent (Figure 1-8B). On the other 
hand, there are some examples of parallel strands connecting via loops running on the 
outside of the guanine tetrad core (Figure 1-8C), which indicates that the spectra of 
unimolecular structures may be more complex than prospected here.28 
 
Figure 1-8.  Strand connectivity alternatives for unimolecular guanine tetrad 
structures 
 
1.2.2.3 Possible Roles of G-quadruplex in vivo 
Little attention was paid to the phenomenon of guanine tetrads for more than 
20 years since it was elucidated in 1962 by David R. Davies. Until 1980s, emerging 
interest in G-quadruplex structure was stimulated by several implications of its 
existence in various biologically important genomic regions such as telomeres.29, 30 
For example, these structures were suggested to participate in telomere regulations.  
In addition, it is believed that G-quadruplex is responsible for the switch 
recombination to bring different constant regions next to variable regions during the 
differentiation of B lymphocytes.31 
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In addition, telomeres are the specialized ends of linear chromosomes 
comprising tandemly-repeated short DNA sequences.32 Various proteins are involved 
in regulating the structure and function of human telomeres, including telomerase and 
some telomere-interacting proteins such as Pot1, TRF1 and TRF2. It is well known 
that telomeres are essential for genome integrity and appear to play an important role 
in cellular aging and cancer. In almost all organisms, the telomeric DNA sequence has 
a G-rich 3’ overhang, such as “TTAGGG” in vertebrates or “TTGGGG” in ciliate 
Tetrahymena. The length of the sequences can range from a dozens to thousands of 
such repeats. Generally, the last few hundred based of G-rich strand in telomeres is 
thought to be in single-stranded form.32  Besides present at the ends of telomeres, 
guanine-rich sequences are found in a number of important DNA regions, such as in 
the immunoglobulin switch regions and gene promoter region of c-myc and other 
oncogenes.36 Moreover, several G-quadruplex-binding proteins have been identified 
over the past 10 years.32-35 It consequently becomes apparent that G-quadruplex could 
play certain significant roles in various types of biological processes. 
1.2.2.3.1 G-quadruplex-Interactive Proteins 
Many proteins, mostly from ciliates and yeast, have been found to bind to G-
quadruplex structures.32-40 Among these, yeast RAP1 protein34 and beta-subunit of 
Oxytricha telomere binding protein37 are the most interesting ones because they not 
only bind to G-quadruplex but also facilitate the formation of these structures. In 
addition, four helicases, the Simian Virus (SV) 40 large T-antigen,41 Bloom’s 
syndrome helicase (BLM) from yeast, and Werner syndrome helicase from humans42 
have been found to unwind G-quadruplex DNA. Another enzyme that could interact 
with quadruplex structures is human DNA topoisomerase I (Topo I). 43 Arimondo et. 
al. demonstrated that Topo I can bind to both linear, four-stranded quadruplexes and 
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unimolecular quadruplexes. Moreover, it was demonstrated that this enzyme can 
induce the formation of four-stranded G-quartet structures. 43 
1.2.2.3.2 Telomere Protection and Elongation  
Telomeric proteins are known to bind both double-helical telomeric DNA as 
well as single-stranded, non-quadruplexed telomeric DNA. Zahler et. al44 illustrated 
that the folded quadruplex form of the 3’ telomere overhang is a poor substrate for 
telomerase, and accordingly proposed that quadruplex formation may play a role in 
the negative regulation of telomerase-based replication.45-46 
Formation of G-quadruplex structure to afford 3’ overhang protection has been 
proposed as the molecular mechanism for telomere protection.47 It was suggested that 
the 3’ overhang could fold over to form an intramolecular G-quadruplex. Such 
structures are most likely to form during replication when long single-stranded G-rich 
tails are expected to be transiently present47 (Figure 1-9A). It was further 
demonstrated that certain single-stranded G-rich overhang might fold back to form a 
hairpin structure involving G-G base pairing (Figure 1-9B).46 Two such hairpins from 
different chromosomes can then dimerize to form a G-quadruplex structure and help 
the alignment of sister chromatins. 
                 








Figure 1-9. Possible biological roles of G-quadruplexes 
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1.2.2.3.3 Interaction of Small-Molecule with G-Quadruplex 
Zahler et. al. demonstrated in 1991 that K+-stabilized G-quadruplex structures 
were able to inhibit telomerase activity. 48 Since then, G-quadruplex DNA has become 
an attractive target for design of telomerase inhibitors. 49 Several groups subsequently 
used structure-based design approach to develop lead compounds that interact with G-
quadruplexes in order to inhibit telomerase activity and disrupt the function of 
telomeres.50, 51 After the original discovery of G-quadruplex interactive telomerase 
inhibitors (e.g. anthraquinones), a number of compounds such as fluorenones, bi-
substituted acridines and cationic porphyrins have been identified, and their 
interactions with G-quadruplex have also been studied extensively.52-55  
 
1.3 i-Motif Structure of DNA 
Besides G-quadruplex form of DNA, certain Cytosine-rich oligonucleotides 
could form tetraplex assemblies at low pH,56  namely i-motif. The structural entity is 
composed of two parallel-stranded DNA duplexes zipped together in an antiparallel 
orientation and held together by hemiprotonated C·C+ base pairs. 56-60 NMR studies 
showed that the same C-rich strands of oligodeoxynucleotides can form intercalated 

















          
Figure 1-10. Illustration of C·C+ interaction in i-motif structure of DNA 
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1.3.1 Discovery of i-Motif Form of DNA 
In 1993, Gehring et. al 56 demonstrated that certain oligomers containing tracts 
of cytidine could form hemiprotonated base pairs at acid pH. This research group 
solved the structure of d(TCCCCC) and found that it was a four-stranded complex in 
which two base-paired parallel-stranded duplexes were intimately associated and their 
base pairs were fully intercalated. Subsequent NMR analysis showed only six spin 
systems, indicating that the structure is highly symmetrical on the NMR timescale and 
the four strands are equivalent.56, 61 The outcomes of these studies demonstrated that 
certain C-riched sequences could exist indeed in tetraplex forms of i-motif as 
illustrated in Figure 1-10. 
1.3.2 Stoichiometries and Topologies of i-Motif DNA 
 
Figure 1-11. i-motif structures with (a) four, (b) two and (c) one strand(s) 
i-Motif is the only known nucleic acid structure containing systematic base 
intercalation,58 in which two cytidine stretches form a parallel-strand duplex via C·C+ 
base pairs and two such duplexes associate head-to-tail by base-pair intercalations 
into a quadruplex. (Figure 1-11) The intercalated structure is partially stabilized by 
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interactions of hydrogen-bonded protonated and neutral cytosines. Consequently, 
formation of i-motif structure generally require acidic environment in order to 
protonate one of the cytidines in C·C+ base pairs (pKa = 6.2).57-60 It has been 
suggested that telomeric C-rich strands of tetrahymena and of vertebrates may fold 
into a monomeric i-motif that persisted at pH 7.0 despite the requirement for cytidine 
protonation. The structural feature of i-motif is accordingly expected to play certain 
biological roles in vivo.62   
In addition, as shown in Figure 1-11, oligonucleotides such as d (Cn) can 
form two fully intercalated i-motif tetramers (Figure 1-11a) that differ in their 
intercalation topologies, the outer cytidine being either that on the 3’ end or that on 
the 5’end of the stretch. Structures with different intercalation topologies may have 
comparable stabilities. Certain i-motif can also be formed in a dimer form (Figure 1-
11b) of a DNA containing two cytidine stretches and an intermediate linker or by 
intramolecular folding of a single strand with four cytidine stretches (Figure 1-11c).60 
The intercalation and loop topologies are susceptible to the linker sequence.  
Studies on certain oligonucleotides derived from fragments of natural 
sequences were carried out in several research groups in the past years to explore the 
possible biological or pharmaceutical relevance of i-motif.58 One of the examples is 
the study of d(TAACCC), the sequence repeatedly occurred in human telomere. It 
was consequently demonstrated that this C-riched sequence existed in the form of i-
motif when crystalised.58 Furthermore, at each end of the i-motif core, one of the two 
TAA sequences loops could form an A-T pair that is stacked above the core.56 Many 
efforts have also been made to study the intramolecular folding of DNA strands 
containing four cytidine stretches61, the first high-definition structure of the sequence 
d(5mCCT3CCT3ACCT3CC) was obtained from NMR studies in 1998.63 
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1.3.3 Biological Role of i-Motif Structure of DNA 
A number of proteins that interact with the G-quadruplexes have been 
identified in the past,32-40 in either unfolded or tetrad form. On the other hand, it is 
shown that i-motif may also play certain biological roles in vivo. For example, it was 
formed that some proteins could interact selectively with repeats of the telomeric 
cytosine-rich strand, possibly in the i-motif form.64, 65 A protein of high molecular 
mass (160 kDa) that binds the cytosine-rich strand of the centromeric dodeca-satellite 
of Drosophila has also been characterized by Azorin and co-workers in 1999.64 In 
addition, two human nuclear proteins, hnRNP K and the splicing factor ASF/SF2, 





Construction of i-Motif-Based DNA Machines 
 
2.1 Background and Aims 
2.1.1 Biomolecular Machines in Organisms  
The concept of a macroscopic machine has been extended to the molecular 
level (molecular machine) in the past few decades.66-69 Molecular machines can be 
defined as devices that conduct specific function through interactions of distinct 
molecular components.66 Each molecular component performs a single action while 
the entire assembly performs a more complex function which can convert certain 
forms of energy to mechanical work.67 Molecular machines are generally more 
efficient as compared with the macroscopic machinery. The machineries at the 
molecular level are generally fueled with chemical energy, electrical energy and 
photochemical energy for their mechanical actions. 67 
Nature creates its own set of molecular motors that have been working for 
millions of years inside the living systems. The bounden duty of these machines 
endowed by nature is to transform energy from one form to another in order to 
maintain cellular structures and functions. Most of these molecular machines are 
protein-based and rely on the energy-rich molecules (e.g. ATP) for their function. So 
far, two kinds of existing nature molecular machines have been well characterized. 
The first one is the F0F1-ATPase molecular motor (Figure 2-1). These motor proteins, 
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which are found in mitochondria, bacteria and chloroplasts, convert the energy stored 
in a transmembrane proton gradient to chemical energy (ATP).68 The second type in 
this category is bacterial flagellar motors.69 The movement of bacterial in most cases 
is driven by its flagella motors. The rotary motions of the flagella motors are 
commonly powered by protons flowing through cell membrane, a process in which 
chemical energy is transduced to mechanical motion.  
These natural molecular machines have been developed and optimized during 
millions of years’ evolutionary process. Even though they have adopted extremely 
complicated systems for their actions which are unlikely to be reproduced in the 
laboratory,67  scientists have successfully made use of DNA molecules to build 
artificial molecular machines to mimic the natural molecular machinery. 88, 89 
 
Figure 2-1. The F0F1-ATPase molecular motor 
2.1.2 DNA-based Artificial Molecular Machines  
Inspired by the wonder of biomolecular machinery found in nature, much 
attention has been paid to the development of artificial molecule machine which can 
fulfill certain mechanical functions.70-73 Because of some unique characteristics of 
DNA, this type of biomacromolecule has been considered as an ideal building block 
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in molecular nanotechnology.70 For example, one of the distinctive properties of DNA 
is the elastic properties of double strand DNA (dsDNA) which leads to desired 
bending rigidity and twisting rigidity of the biomacromolecule.70 In addition, DNA 
can be designed to self-assemble in a preferable fashion.71-73 Moreover, since some of 
the DNA structures possess conformational isomers, control of transformation 
between isomers are attractive for the fabrication of switching devices. Various DNA 
sequences have therefore been utilized over the years for the construction of 
molecular wires, molecular grids, and other nanoscale molecular objects. 
One of the most innovative DNA-based molecular switches was developed by 
Seeman and co-workers in 199974. This DNA switch is comprised of two rigid DNA 
double-crossover (DX) motifs (Figure 2-2). The reversible transformation between B-
form (right-handed) and Z-form (left-handed) of DNA can be triggered by additional 
of metal ions. The main strand of this molecule switch contains two short d(CG)10 
domains, which are designed to form intramolecularly a duplex structure in the 
middle of the DNA motif. Two fluorescent probes are incorporated site-specifically 
into the DNA motif at certain positions.  The duplex section is transformed from B to 
Z upon addition of Co(NH3)63+ which is accompanied by twisting of the DNA motif 
at duplex domain. 
 
Figure 2-2. DNA-based twisting molecular switch  
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In addition, Yurke and co-workers75 designed certain artificial molecular 
machines based on intermolecular DNA hybridization. This special device mimics the 
function of tweezers at the molecular level through using three strands of DNA (DNA 
tweezers, Figure 2-3). In this system, strand A were hybridized to each end of strands 
B and C to form two arm-like double-stranded structures (Figure 2-3).75 In its open 
conformation, fluorophore and quencher are separated apart. Addition of the DNA 
strand F, which is complementary to the single stranded form of DNA could result in a 
closure of the “open” tweezers to generate a compact configuration (state 5 in Figure 
2-3). This effect is reversed by the addition of strand F’, which is fully 
complementary to F. 
 
Figure 2-3. DNA tweezers 75 
Using similar principles, Simmel and Yurke76 developed a DNA nanoactuator 
which can switch from a relaxed, circular form to a stretched conformation. 
Additional example of DNA devices designed in the recent years is called “DNA 
scissors”.77 Mitchell and Yurke demonstrated that two sets of tweezer structures could 
join at their hinges with short carbon linkers under proper conditions. The motion of 
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one set of tweezers could be transduced to the other end of the DNA molecules, 
resulting in a scissor-like movement.77 
Since 2004, several research groups have developed some new molecular 
motors that can direct DNA to walk along designed routes, namely DNA walkers.78 
These DNA walkers move along single-stranded nucleic acid tracks and are fixed to 
the track throughout the entire operation. The actions of some of the DNA walkers are 
illustrated in Figure 2-4. 78 
 
Figure 2-4. DNA walkers 78 
2.1.3 Quadruplex DNA-based Molecular Machines  
Structural competitions between G-quadruplex, i-motif and duplexes have 
been investigated by several research groups. For example, Phan & Mergny79 
examined a human telomeric fragment d[AGGG(TTAGGG)3] / [d(CCCTAA)3CCCT] 
under a variety of experiment conditions and studied the conversion of the regular 
double-helix structure into the intramolecular G-quadruplex and i-motif. They 
demonstrated that DNA predominantly exists in the double-helix form under near-
physiological condition while at lower pH or higher temperatures, duplex structure 
could dissociate and G-quadruplex and i-motif will form. Furthermore, Li et. al.80 
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observed that under certain circumstances, formation of quadruplex and duplex of 
DNA depended on thermal stabilities of the corresponding DNA assemblies. 
Moreover, Risitano & Fox81 observed that stability of the quadruplex does not 
increase with the increase of length of G-tract and linking bases. All these 
investigations imply that G-quadruplex DNA could be more favorable under specific 
conditions. 
 
Figure 2-5. A quadruplex-duplex exchange nanomachine 82 
Taking advantage of unique structural properties of i-motif and G-quadruplex 
forms of DNA, scientist have developed different types of nanodevices using these 
tetraplex forms of DNA since 1990s.87-89 For example, Alberti & Mergny82 introduced 
“C-fuel” and “G-fuel” into a nanodevice and demonstrated the manipulation of an 
extension-contraction cyclic movement. This simple device is composed of a single 
21-mer oligonucleotide and relies on the duplex / quadruplex equilibrium for its 
action. The single strand is initially folded into a qudruplex structure and subsequent 
addition of a complementary C-strand will force it to form a duplex assembly. After 
addition of G-fuel which is complementary to C-fuel, the corresponding G-rich strand 
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will be released and further self-assemble into a quaduplex structure (Figure 2-5).82 
Simmel and co-workers extended this approach to biological systems and used 
the structure of aptamer in their construction of a nanomachine, which can bind and 
release a single protein molecule.83 The aptamer sequence used in Simmel’s studies 
could fold into a two layers G-quartets in the presence of potassium ion and bind 
strongly to a human blood-clotting protein, thrombin. As shown in Figure 2-6, upon 
addition of single-stranded DNA that is complementary to a portion of the aptamer 
sequence, a duplex structure is formed, which leads to the release of the 
corresponding protein. The operation of this machine can be monitored using FRET. 
In this aptamer device, formation and dissociation of G-quadruplex entities were 
involved and further utilized.83 
 
Figure 2-6. A switchable aptamer device 83 
In addition, Bourdoncle et. al. 84 built the quadruplex-based molecular beacons 
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using G-quadruplex as stem in which a central loop is composed of 12 to 21 bases. 
The central loop hybridizes and forms a duplex structure which helps opening process 
of the quadruplex stem. The quadruplex-based molecular beacon (G4-MB) can be 
formed during the equilibrium process. Detailed thermodynamic and kinetic 
investigations in these new systems were also carried out by these researchers.84  
Besides the widely used strand displacement strategy, variation of 
environmental medium was utilized in the design of the quadruplex-DNA-based 
nanomachines. For example, Liedl & Simmel85 constructed a chemical oscillator via 
controlling the formation and dissociation of i-motif structures. This specific 
oscillatory reaction could produce pH variations in the range between pH 5 and 7. 
Association and dissociation of i-motif structure was accordingly regulated via 
variation of pH within this pH range. The cytosine-rich DNA sequence is transformed 
between a random coil conformation and a folded i-motif structure under this 
condition.  
In addition, through manipulating molecular devices via chemical reactions 
reported by Simmel et. al., physical regulation could also be adopted in the design of 
molecular devices. S. Balasubramanian and co-workers86 used protons to fuel a 
nanomachine which can be controlled between an i-motif conformation and an 
extended double-stranded structure (Figure 2-7). At low pH values, self-assemble of 
i-motif structure on the basis of C-C+ interaction are involved; At higher pH values, 
cytosine is deprotonated and X strand in Figure 2-7 can hybridize with the 
complementary strand Y to form a duplex structure (open state). 
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Figure 2-7. A Proton-Fuelled DNA Nanomachine86 
 
Even though various artificial DNA machines have been developed in the past 
87-89 including those designed on the basis of G-quadruplex, application of i-motif 
structure in the design of molecular devices has not yet been well explored. Inspired 
by the natural beauty of molecular machines adopted by organism and with the 
intention of exploiting the possibility of designing new DNA machines which can 
perform well-defined actions (e.g. Watson-Crick breakage), an i-motif-based DNA 
machine has been designed and constructed during my graduate studies that can take 
in chemical energy associated with acid-base reactions and further convert it to a new 
type of mechanical work. Design, synthesis and operation of this i-motif-based DNA 
machine are discussed in the following sections of this chapter.  
2.2 Our Strategies in Design of i-Motif-Based DNA Machines 
Let us imagine that there is a two-way electric winch that is hooked to the 
ends of a bow (Figure 2-8). The electric winch takes in its cables gradually; the two 
ends of the bow will be forced to move toward each other in a steady manner.  If the 
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main body of the bow is tied up simultaneously to a still wall with breakable ropes, 
these fragile linkages will have to endure a force originated from the arm movement 
of the bow. Over this course of action, the electric winch converts electrical energy 
into mechanical work that leads ultimately to the fractures of the fragile ropes 









Figure 2-8. Illustration of our designed DNA-based molecular machine 
Similar to the connecting fashion between the wall and bow on the 
macroscopic scale to a certain extent, duplex structures of two complementary DNA 
strands are held together via Watson-Crick interaction, which are inseparable unless 
certain forms of external energy are imposed on them. During replication, 
transcription and other genetic processes in vivo, dissociation of these duplex forms 
of DNA are executed by helicase,90  a protein motor that takes up chemical energy 
derived from nucleotide hydrolysis.91 Our approach to break down Watson-Crick 
interaction in this study is  to covalently link two termini of one of the two 
complementary oligonucleotide strands to a cytosine-rich sequence. Under a neutral 
condition, the two ends of a cytosine-rich oligonucleotide will position themselves 
randomly and might not be able to get close to each other readily due to the rigidity of 
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DNA backbone.92 Formation of a structural entity of i-motif under an acidic condition, 
however, will force the two ends of this cytosine-rich sequence to move towards each 
other.92 It was envisioned during our early investigations that in the process of 
formation and disassociation of i-motif, a cytosine-rich sequence could act in the 
same fashion as an electric winch does on the macroscopic scale (Figure 2-8).  
A duplex structure-containing complex was accordingly designed during our 
investigations that was constituted of a circular oligonucleotide of 36-mer 
(<C1CCCT5TTCCC10CTTTC15CCCTT20TCCCC25AAAAT30TAAAA35A>, Sequence 
1) and a linear oligonucleotide of 19-mer tagged with BODIPY and DABCYL at its 5’ 
and 3’ ends (5' BODIPY-ATATTTTTTAATTTTATAT-DABCYL 3', Sequence 
2).  This circular sequence (Sequence 1) contained both a cytosine-rich stretch (25 
nucleotides in length) and a non-cytosine-containing tract (11 nucleotides in length) 
respectively, the former possessing an innate ability to form a structural assembly of i-
motif, and the latter being complementary partially to Sequence 2.  It was our 
anticipation that under a neutral condition, Sequence 1 and Sequence 2 would be held 
together by Watson-Crick interaction in a tight fashion (State 1 in Figure 2-9C) via 
the two complementary segments that they contain.  As pH decreased, the cytosine-
rich stretch of Sequence 1 would form a structural entity of i-motif,92 which would 
consequently drive Nucleotide A26 and Nucleotide A36 of Sequence 1 to move close 
to each other (State 2 in Figure 2-9C).  This forced movement of A26 and A36 could, 
in theory, cause sever backbone bending on the non-cytosine segment (-
A26AAAT30TAAAA35A-) of this circular oligonucleotide.  Since there was no 
additional physical force to compel the backbone of Sequence 2 to bend along with 
the non-cytosine segment of Sequence 1, duplex structure between these two 
sequences would be disintegrated (Figure 2-9C) as a consequence.  During this 
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course of action, chemical energy associated with acid-base reactions would be 
converted into physical work that leads to the breakdown of Watson-Crick interaction.   
 



















Sequence 1 (circular 36-mer):
<C1CCCT5TTCCC10CTTTC15CCCTT20TCCCC25AAAAT30TAAAA35A>
Sequence 2 (linear 19-mer tagged with a fluorophore and its quencher):




















Figure 2-9.  Schematic representation of our strategy for designing a new energy-
converting DNA machine capable of breaking down Watson-Crick interaction. 
 
(A)  Formation and dissociation of structural entity of i-motif as the pH value of its 
environment varies. 
(B) Transformation of chemical energy coupled with acid-base reaction to elastic 
potential energy within a circularly-backboned DNA. 
(C)  Transformation of chemical energy coupled with acid-base reaction to 
electrical potential energy and breakdown of Watson-Crick interaction. 
 26
 
As pH changes from acidic back to neutral, the elastic potential energy stored 
in the form of backbone bending will be librated to its environment as the structural 
entity of i-motif falls apart. Under neutral condition, Sequence 1 and Sequence 2 will 
form an 11-mer duplex structure via their complementary segments, an entity 
sustained by hydrogen bonding (electrostatic attraction) (State 1 in Figure 2-9C).  As 
pH decreases, a high degree of curvature on the non-cytosine segment will be forced 
to occur by the formation of structural entity of i-motif. Owing to the absence of extra 
force to drive Sequence 2 to curve with its complementary segment, the 
corresponding Watson-Crick base pairs will be detected, leading to an electrical 
potential energy increase of the system in the form of dissociated dipolar groups 
preserved in the single stranded oligonucleotides (vi and vii in Figure 2-9C).  At the 
same time as electrostatic interactions are broken down, the resultant single stranded 
form of Sequence 2 (v) will adopt a stem-and-loop conformation (vii) in which 
fluorescence signal of Bodipy is quenched to a high extent.  When the elastic potential 
energy stored in vii is allowed to liberate next by increasing the pH of the system, the 
electrical potential energy stored in the single stranded form of this oligonucleotide 
will be discharged by regenerating electrostatic attraction between the two 
complementary segments from Sequence 1 and Sequence 2 respectively.  At the same 
time as a duplex structure is reestablished, fluorescence signal of Bodipy is being 
restored. 
 
2.3 Synthesis of Our Newly Designed i-Motif-Based DNA Machines 
Sequence 1 was accordingly synthesized through the enzymatic ligation 
reaction of two termini of a linear 36-mer oligonucleotide (5’ 
TAAAAACCCCTTTCCCCTTTCCCCTTTCCCCAAAAT 3’, Sequence 3) catalyzed 
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by T4 DNA ligase in the presence of a template sequence (Sequence 4, 
GGTTTTTAATTTTGG). The reaction mixture containing 1 μM Sequence 3, 3 μM 
Sequence 4, 1 x T4 DNA ligase buffer (50 mM Tris-HCl, 10 mM MgCl2, 10 mM 
DTT, 1 mM ATP, 25 μg/ml BSA, pH 7.8), 30 mM NaCl and 100 U T4 DNA ligase 
were incubated at 20 °C for different periods of time. Radioactive strand of Sequence 
3 was prepared by phosphorylation of the synthetic sequence at 5’ end with T4 
polynucleotide kinase and [γ-32P] ATP. The phosphate transfer reaction between [γ-32P] 
ATP and the 5’ hydroxyl-ended Sequence 3 was catalyzed by the kinase. (Refer to 
“6.2.1 5’ End labeling of DNA” for detailed procedures.) The ratio of the linear 
precursor and the template sequence is 1:3. The circularization was performed at 20 
°C, under which the duplex structure could be sustained. It takes about 1 hour to 
complete the circularization reaction. As shown in Figure 2-10A, a clear band with 
lower mobility shift than the linear precursor appeared on the gel which was proved to 
be the circular product in later studies. 
The circular nature of this newly formed oligonucleotide in its backbone was 
subsequently confirmed by examining its resistance to hydrolysis by exonuclease I.  
The reaction mixture containing 1 x exonuclease I  buffer (67 mM Glycine-KOH, 6.7 
mM MgCl2, 10 mM 2-mercaptoethanol, pH 9.5), oligonucleotides (Sequence 1 or 
Sequence 3) and 80 U exonuclease I was incubated at 37 °C for 60 min. As shown in 
Figure 2-10B, the newly formed product was completely resistant to the enzyme 
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Figure 2-10.  Polyacrylamide gel electrophoretic analysis of oligonucleotides as 
components of the artificial DNA machines designed in our study. 
 
(A) Synthesis of Sequence 1. Lane 2: 5 min, lane 3: 10 min, lane 4: 30 min, lane 5: 60 
min.  (B) Confirmation of circularity of Sequence 2 in its backbone. Lane 1: 
Sequence 3 in the absence of exonuclease I (as control), lane 2: Sequence 3 in the 
presence of exonuclease I, lane 3: Sequence 1 in the absence of exonuclease I (as 
control), lane 4: Sequence 1 in the presence of exonuclease I. 
 
2.4 Operation of Our i-Motif-Based DNA Machines 
2.4.1 First Half and Second Half of Operating Cycle 
It is known that BODIPY dyes possess: 93  
a) High extinction coefficients (>60,000 cm-1 M-1); 
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b) High fluorescence quantum yields (often approaching 1.0, even in water); 
c) Fluorescence is pH-insensitive;94 
d) No ionic charge; 
e) Narrow emission bandwidths; and 
f) Greater photostability than fluorescein in some environments. 
In addition, it was demonstrated by Vos de Wael, et. al.95 that the BODIPY  
493/503 fluorophores are brilliantly fluorescent in a wide range of solvents. A 
BODIPY 493/503 was consequently selected during our investigation which was 
linked to 5’ end of particularly designed oligonucleotides (Figure 2-11). This 5’ end 
labeled Bodipy 493/503 has a maximum of fluorescence emission of 515 nm when it 
is excited at 480 nm86 and is insensitive to pH variation from 2 to 8.5.93 On the other 
hand, DABCYL was linked to 3’ end of the oligonucleotide, which serves as a 
















Figure 2-11.  Structure of Bodipy 493/503 modification on 5’ end of oligonucleotide 
A sample containing Sequence 1 and BODIPY-tagged Sequence 2 in an equal 
ratio was accordingly examined next at 20 °C using fluorescence spectroscopy.  As 
shown in Figure 2-12A, the emission intensity of this sample at 515 nm increased 
from 83 a.u. to 503 a.u. with the increase of pH from ~5.5 to ~7.5.  These 
observations were consistent with the suggestion that Sequence 2 existed in a stem-
and-loop conformation at ~pH 5.5 (Structure 1 in Figure 2-9C) and was further 
transformed into a stem-open duplex structure with Sequence 1 at ~pH 7.5 (State 2 in 
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Figure 2-9C).  Subsequent variation of pH of the same system from ~7.5 to ~5.5 led 
to a decrease of emission intensity from 493 a.u. to 87 a.u. (Figure 2-12B).  This 
dramatic reduction of emission intensity indicates that the stem-open form of 
Sequence 2 was further transformed back to its stem-and-loop conformation (from 
State 1 to State 2 in Figure 2-9C) under an acidic condition.97 These conformational 
alterations of Sequence 2 implied that a breakdown of Watson-Crick interaction 






















































Figure 2-12. Fluorescence Spectroscopic analysis of formation and disintegration of 
duplex structure associated with the artificial devices designed in the current studies. 
(A) Emission spectra of Sequence 1 and Sequence 2 as pH increases. Fluorescence 
spectra of a sample containing 1 μM Sequence 1, 1 μM Sequence 2, 10 mM 
MES/HEPES (pH 7.5) and 1 M NaCl was recorded at 20 °C with excitation at 480 nm. 
Variation of pH was carried out by addition of 1 M NaOH to the system in a stepwise 
fashion.  
(B) Emission spectra of Sequence 1 and Sequence 2 as pH decreases. Fluorescence 
spectra of a sample containing 1 μM Sequence 1, 1 μM Sequence 2, 10 mM 
MES/HEPES (pH 5.5) and 1 M NaCl was recorded at 20 °C with excitation at 480 nm. 
Variation of pH was carried out by addition of 1 M HCl to the system in a stepwise 
fashion. 
With the aim of confirming that the changes of emission intensity shown in 
Figure 2-12A and Figure 2-12B were indeed correlated with the formation of i-motif, 
a sample consisting of Sequence 2 and its complementary 11-mer of non-cytosine-
containing oligonucleotide  (5’ AAAATTAAAAA 3’, Sequence 5) was examined 
under different pH conditions using fluorescence spectroscopy. In theory, Sequence 2 
and Sequence 5 would assemble together to form a duplex structure under a neutral 
condition while such a structural entity would be maintained in an acidic environment. 
As seen in Figure 2-13b, there was little alternation of emission intensity occurred 
when the pH of a sample containing Sequence 2 and Sequence 5 decreased from ~7.5 
to ~5.5 as well as increased from ~5.5 to ~7.5. These observations demonstrate that a 
cytosine-rich segment is an essential component of the DNA machine designed in the 
studies.  In addition, the absence of dramatic change of emission intensity with pH 
variation (Figure 2-13b) rules out the possibility that the alterations of emission 
intensity in Figure 2-12A and Figure 2-12B are caused by the protonation of the 
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Figure 2-13. Analysis of dissociation and formation of duplex structure correlated 
with the artificial machines using fluorescence spectroscopy. 
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a) Illustration of correlation among Sequence 1, Sequence 2 and Sequence 5 under 
different conditions.  
 
b) Emission spectra of Sequence 2 and Sequence 5. A mixture containing 1 μM 
Sequence 2, 1 μM Sequence 5, 10 mM MES/HEPES and 1 M NaCl at pH 7.5 was 
prepared and its emission spectrum was recorded at 20 °C with excitation at 480 nm 
(Black). 1 M HCl was added next to the above solution until pH reached ~5.5 (Blue) 
followed by the adjustment of pH of the new mixture to pH ~7.5 through adding 1 M 
NaOH (Red).   
  
c) Emission spectra of Sequence 1, Sequence 2 and Sequence 5 in different 
combinations. A mixture containing 1 μM Sequence 1, 1 μM Sequence 2, 10 mM 
MES/HEPES (pH5.5) and 1 M NaCl was prepared and its emission spectrum was 
recorded at 20 °C with excitation at 480nm (Blue). An equal amount of Sequence 5 to 
that of Sequence 1 was added next to the above solution and an emission spectrum of 
the new solution was further recorded under the same condition (Red). 
 
Mse I is a restriction endonuclease that recognizes TTAA-containing double 
helices of DNA and makes its incisions within this duplex segment98 (detailed 
information refer to Chapter 6.1.2).  To further prove that a duplex structure between 
Sequence 1 and Sequence 2 did indeed exist under neutral condition (State 1 in 
Figure 2-9C), a DNA cleavage test with Mse I was carried out during our 
investigations.  As shown in Figure 2-14, the circular backbone of 32P-labeled 
Sequence 1 was converted into its linear forms when Mse I was added to a mixture 
containing both Sequence 1 and Sequence 2 at pH 7.  This observed strand scission is 
the indication of presence of Watson-Crick interaction in the designated system as 
designed (State 1 in Figure 2-9C).  In addition, with the purpose of further verifying 
that Sequence 1 was truly separated from Sequence 2 under acidic conditions (State 2 
in Figure 2-9C), Sequence 5 (5’ AAAATTAAAAA 3’, complementary partially to 
Sequence 2) was added to a sample containing preincubated Sequence 1 and 
Sequence 2 at pH 5.5. As shown in Figure 2-13c, this addition caused an instant and 
dramatic increase of fluorescence intensity of the sample, which suggests that a stem-

















Figure 2-14.  Confirmation of presence of duplex structure between Sequence 1 and 
Sequence 2 (State 1 in Figure 2-9C) at pH > 6.2. A solution containing 1 μM 
Sequence 2, 1 μM  32P-labled Sequence 1, 1 x Mse I buffer (10 mM Tris-HCl, 
50 mM NaCl, 10 mM MgCl2 1 mM Dithiothreitol, pH 7.9), 100 mM NaCl and 60 U 
Mse I was incubated at 20 °C for different time periods. Lane 3: 10 min, lane 4: 60 
min, lane 5: 120 min, lane 6: 240 min. 
2.4.2 Cyclic Operation of i-Motif-based DNA Machine 
Since assembly and disassembly of i-motif and duplex structures of DNA were 
involved in the functioning process of the DNA machine designed in this study, the 
time scales needed to complete each half of the cycle of the operation were measured 
next.  The obtained response times of this DNA machine to both pH decrease and 
increase were around 10 seconds (Figure 2-15, A and B), which matched up with 
those of similar operations reported in literature.86, 99 Given that a relatively short time 
period was needed for each half of the cycle of the operation, this DNA machine was 
further run in a periodic fashion. For the first half of the cycle, 1 M NaOH was added 
to a solution containing 1 μM Sequence 1, 1 μM Sequence 2, 10 mM of 
MES/HEPES (pH 7.5) and 1 M NaCl in stepwise fashion until pH reached ~5.5. 1 M 
HCl was added next to the above solution until pH reached ~ 7.5 to complete the 
second half of the cycle. Emission intensity at 515 nm was recorded at 20 °C in every 
1 min with excitation at 480 nm. As shown in Figure 2-15C, decrease in fluorescence 
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emission of the system is insignificant over five cycles, indicating that the 
accumulation of waste products generated from acid-base reactions has little effect on 


















































Figure 2-15.  Examination of operability of artificial DNA machines using 
fluorescence spectroscopy. 
(A) Changes of emission intensity in the first half of the cycle as pH decreases from 
7.5 to 5.5. 1 M HCl was added to a solution containing 1 μM of Sequence 1, 1 μM of 
Sequence 2, 10 mM MES/HEPES (pH 7.5) and 1 M NaCl in a stepwise fashion until 
pH reached ~5.5. Emission intensity at 515 nm was recorded at 20 °C in every 2 s 
with excitation at 480 nm. 
 
(B) Changes of emission intensity in the second half of the cycle as pH increases from 
5.5 to 7.5. 1 M NaOH was added to a solution containing 1 μM of Sequence 1, 1 μM 
of Sequence 2, 10 mM of MES/HEPES (pH 7.5) and 1 M NaCl in stepwise fashion 
until pH reached ~7.5.  Emission intensity at 515 nm was recorded at 20 °C in every 2 
s with excitation at 480 nm. 
 
(C) Changes of emission intensity as the designed DNA machines were operated for 
five cycles. 
 
2.4.3 Calculation of Mechanical Energy Released by Our i-Motif-
Based DNA Machine 
Thermal stability of the 11 base pairs (5’ AAAATTAAAAA 3’/5’ 
TTTTAATTTTT 3’) between circular Sequence 1 and molecular beacon was also 
examined by using UV/VIS Spectroscopy.  The observed melting point of this duplex 
entity under the conditions adopted in the current work is 37.8 °C (Figure 2-16), 
which is compatible with the data (35.0 °C, 1 μM Oligo Concentration and 1M NaCl) 
calculated on the basis of empirical estimation (refer to Chapter 6.2.9). All the 
experiments were performed at 20 °C to avoid the thermal denaturing of the complex.  
In addition, according to theoretical calculations,100 the free energy change for 
the formation of this duplex structure from its single-stranded forms is -12.46 kcal 
mol-1 (Table 2-1). This datum implied that the work done in the Watson-Crick 


























Figure 2-16. UV melting curve of the 11 base pairs duplex entity 
 
 
Table 2-1 Calculations of the free energy changed during the formation of duplex 
structure from its single-stranded form. 
 
Ct[Oligo] Tm Tm RTmln(Ct/4) dA ΔS ΔH ΔG(20°C) 
(mol/L) (°C) (K)   (cal/mol.K) (kcal/mol) (kcal/mol)
1.00E-07 29.3 302.5 -43994.82     
2.00E-07 31 304.2 -42490.19 1504.64 211.74 74.57 -12.49 
5.00E-07 33.3 306.5 -40478.08 2012.11 209.29 73.82 -12.47 
1.00E-06 35 308.2 -38927.66 1550.41 218.18 76.55 -12.59 
1.50E-06 36 309.2 -38012.34 915.33 218.98 76.79 -12.60 
2.00E-06 36.8 310 -37369.72 642.61 192.17 68.50 -12.17 
       ∑-12.46 
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2.5 Conclusions 
When a DNA molecule responds to the changes of its environment, its 
conformation often adjusts.  In order to link the conformation changes of DNA with 
desirable forms of energy transformation, a new approach of utilization of backbone-
circularized DNA is introduced into the design of DNA machines during our 
investigation.  It is consequently demonstrated in the current studies that chemical 
energy coupled with acid-base reaction can be transduced into elastic potential energy 
as well as electrical potential energy being preserved in the macromolecules involved.  
As a manifestation of these energy-converting processes, breakdown of Watson-Crick 
interaction is forced to occur under isothermal condition.   
The outcomes of our studies not only illustrate the potentiality and versatility 
of DNA molecules as building blocks for fabricating sophisticated supramolecular 
architectures, but also further ascertain the manipulability of single molecules of DNA 
in terms of force, motion and energy transformations. It is our expectation that 
development of the new energy-converting DNA-based machine could have 
significant implications in the future design of new DNA architectures to carry out 




Search and Confirmation of G-Quadruplex-Based 
Deoxyribozymes  
 
3.1   Background and Aims 
Deoxyribozymes, also known as catalytic DNA, are DNA molecules with 
catalytic action. The first deoxyribozyme was discovered in 1994 by Joyce’s group at 
The Scripps Research Institute.101 This deoxyribozyme assists in lead ion dependent 
RNA cleaving operations. Catalytic amplification was found to be 100-fold compared 
to the uncatalyzed reaction. Many other deoxyribozymes have been developed that 
catalyze DNA phosphorylation, DNA adenylation, DNA deglycosylation, porphyrin 
metalation, thymine dimer photoreversion and DNA cleavage. Of particular interest 
are DNA ligases.102 These molecules have demonstrated remarkable chemoselectivity 
in RNA branching reactions. Although each repeating unit in a RNA strand owns a 
free hydroxyl group, the DNA ligase takes just one of them as a branching starting 
point. In addition, some deoxyribozymes have found practical use in metal 
biosensors.103 
It has been demonstrated that certain catalytic DNA entities such as porphyrin-
metalating deoxyribozyme, HD RNA-cleaving DNA enzyme and ATP-utilizing kinase 
deoxyribozyme utilize G-quadruplex as stable structural cores to sustain their catalytic 
domains and activities.104-107 In order to search for new deoxyribozymes on the basis 
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of G-quadruplex structure, comprehensive studies were carried out during our 
investigations. It was demonstrated that certain particular G-quadruplex structure 
would perform site-specific self-cleaving action under certain reaction conditions.108 
In addition, effect of certain factors such as pH value, DNA concentration, metal ions 
on the self-cleavage processes of G-quadruplex were also carried out. The outcomes 
of our studies on the new types of deoxyribozymes are discussed in the following 
sections of this chapter.  



























































Oligonucleotide 1 Fragment 1 Fragment 2
Oligonucleotide 1: 5' T1G2GGGTTAGGGGAA14A15AGGTTAGGGGTTAG29G30 3' (30-mer)
Fragment 1: 5' T1G2GGGTTAGGGGA13A14 3' (14-mer)
Fragment 2: 5' p-A15A16GGTTAGGGGTTAG29G30 3' (16-mer)




Figure 3-1.  Schematic representation of a self-cleavage process of G-quadruplex 
DNA in this study. 
 
Figure 3-1 depicts a schematic diagram of a DNA self-cleavage processes. A 
guanine-rich 30-mer oligonucleotide was designed with an expectation that this 
oligonucleotide would form an externally looped G-quadruplex assembly (a in Figure 
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3-1) under proper conditions. Our initial intention in designing such a guanine-rich 
oligonucleotide was to examine whether a transesterification reaction could be 
feasible between the hydroxyl group at its 3’ end and the phosphodiester bond 
between A16 and G17 since these functional groups are proximal to each other upon G-
quadruplex formation. Instead of observing such a designed transesterification 
reaction, a self-cleavage reaction of Oligonucleotide 1 at one of the two 
phosphodiester bonds between A14 and A15 was observed by coincidence (Figure 3-1). 
This can be suggested that the self-cleaving reaction of Oligonucleotide 1 took place 
at the one of the phosphodiester bonds near the 3’ end of A14 in the middle of its 



















bond that remains intact
 
Figure 3-2. Diagrammatic illustration of a possible self-cleaving reaction at one of 
the two phosphodiester bonds between A14 and A15 of Oligonucleotide 1. 
 
Oligonucleotide 1 was phosphorylated at its 5’ end with [γ-32P] ATP in the 
presence of T4 polynucleotide kinase and further purified by polyarylamide gel 
electrophoresis and NAP-25 column. In order to allow the formation of proper G-
quadruplex assemblies, this guanine-rich oligonucleotide was incubated at room 
temperature in the presence of 5 mM KCl for 2 hours. The self-cleavage reactions of 
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Oligonucleotide 1 were initiated by adding Histidine/MgCl2 mixture, which was 
further kept at 30 °C for a different period of time. As shown in Figure 3-3, a new fast 
moving band was observed when such a reaction was allowed to proceed for 2 hours 
(band 1 in Lane 2). The mobility shift of this new band is close to that of a molecular 
weight marker of 14-mer (5’ *p-TGGGGTTAGGGGAA 3’, Lane 5), which implied 
that a cleavage reaction took place between A14 and A15 of this guanine-rich sequence.  
The yield of the self-cleavage reactions increased with the increase of reaction time 





Lane              1         2          3          4          5
band 1
 
Figure 3-3.  Polyacrylamide gel electrophoretic analysis of self-cleavage of DNA. 
Lane 1: Oligonucleotide 1 alone; Lanes 2: self-cleavage reactions lasting for 2 h; 
Lane 3: a 15-mer Oligonucleotide (*p-TGGGGTTAGGGGAAA) alone; Lane 4: a 14-
mer (*p-TGGGGTTAGGGGAA) alone; Lane 5: a 13-mer (*p-TGGGGTTAGGGGA) 
alone. 
 
If a DNA cleavage reaction indeed occurred in the middle of the sequence of 
Oligonucleotide 1 in our studies, a second fragment of 16-mer should in theory be 
generated at the same time.  In order to visualize the two fragments simultaneously, 
SYBER Green staining experiments were conducted next.  As shown in Figure 3-4, 
two fast moving bands (Band 1 and Band 2 in Lane 2-5) were visible from the stained 
polyacrylamide gel, which displayed the same mobility shifts as those of a 14-mer 
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marker (Lane 6) and a 16-mer marker (Lane 7) respectively. These electrophoretic 
analysis data are the indications that a cleavage reaction indeed took place between 






1       2      3       4      5       6       7Lane
 
Figure 3-4. Polyacrylamide gel electrophoretic analysis of self-cleavage of DNA 
visualized by SYBER Green staining.  Lane 1: Oligonucleotide 1 alone; Lane 2-5: 
self-cleavage reaction lasting for 2 hr (1 μM Oligonucleotide 1 assay). Lane 6: a 16-
mer (5’ AAGGTTAGGGGTTAGG 3’) alone; Lane 7: a 14-mer (5’ 
TGGGGTTAGGGGAA 3’) alone. 
 
3.3 Effect of certain factors on the G-quadruplex-based self-cleavage 
reaction 
3.3.1 Metal ion dependence 
One of the distinguishable characteristics of G-quadruplexes from other 
structural features of nucleic acids is its selective interaction with certain cations that 
fit in the central cavities formed by guanine tetrads.109 It has been well established in 
the past that the preference of monovalent ions by G-quartet in their interactions is in 
the following order:  K+>>Na+>Rb+>Cs+>Li+.109 As was examined, potassium ion is 
required in this DNA-cleaving reaction. With the intention of knowing how variation 
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of monovalent ions could affect the self-cleavage reactions of G-quadruplex, K+ was 
replaced with Li+, Na+, Rb+ and Cs+ in this study. As shown in Figure 3-5, a self-
cleavage product was generated when Oligonucleotide 1 was incubated with 5 mM 
K+ at 20°C for 2 h followed by addition of Mg2+/Histidine to activate the self-
cleavage reaction as expected. However, there was no cleavage product observable 
when K+ was replaced with Li+, Na+, Rb+ and Cs+ respectively. The absence of 
cleavage product in the presence of these four new alkaline ions could be caused by 
the reason that the G-quadruplex structures containing these four alkali ions might not 
be able to sustain the right conformation of G-quadruplex needed for the 
corresponding self-cleavage reaction.  





 Figure 3-5. PAGE analysis of self-cleavage of Oligonucleotide 1 in the presence of 
5 mM alkaline metal ions (Li+, Na+, K+, Rb+ and Cs+) 
 
Besides alkaline metal ions, it is known that certain alkaline earth and 
transition metal ions could stabilize G-quadruplex assemblies through occupying the 
central cavity as alkaline ions do.110 With the aim of examining how these divalent 
ions affect the self-cleavage reactions of G-quadruplex, K+ was replaced with Mg2+, 
Ca2+, Sr2+, Ba2+, Zn2+, Mn2+, Ni2+, Co2+ and Pb2+. As shown in Figure 3-6, there is no 
cleavage product generated in the presence of Zn2+, Mn2+, Ni2+, Co2+ and Pb2+ while a 
new band was formed between 14-mer and 30-mer when K+ was replaced by Mg2+, 
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Ca2+ and Sr2+ (Figure 3-7). Our subsequently investigation revealed that the fast 
moving band (band 1 in lane 3, 4 and 5) correspond to an intact G-quadruplex 
structure rather than a low molecular weight self-cleavage product. This happened 
most likely because the G-quadruplex structures of Oligonucleotide 1 containing Sr2+ 
Ca2+ and Mg2+ were too stable to be disintegrated by denaturing polyacrylamide gel 
electrophoresis. Interestingly, on the other hand, when K+ was replace with Ba2+, self-
cleavage product of Oligonucleotide 1 was observed (lane 6 in Figure 3-7), which 
indicates that K+ is not the only metal ion that could sustain the G-quadruplex 
structure required for next step self-cleavage reactions. 




Figure 3-6 PAGE analysis of self-cleavage of Oligonucleotide 1 in the presence of 1 
mM transition metal ions (Zn2+, Pb2+, Ni2+, Co2+ and Mn2+). 
 





lane 1 2 3 4 5 6
  
Figure 3-7 PAGE analysis of self-cleavage of Oligonucleotide 1 in the presence of 5 
mM alkaline earth metal ions (Mg2+, Ca2+, Sr2+ and Ba2+). 
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3.3.2 pH dependence 
Catalytic activities of enzymes are commonly affected by the changes of their 
surrounding pH values.111 In order to understand the effect of variation of pH value on 
the reactivity of Oligonucleotide 1, the self-cleavage reactions of this guanine-riched 
oligonucleotide at certain different pH were accordingly carried out. As seen in 
Figure 3-8, the maximum yield of the self-cleavage reactions occurred in the pH 
range from 6.5 to 7.5. As shown in Figure 3-8b, when pH value was set to above 7.5 
or below 6.5, a phenomenon similar to many enzymatic processes. On the other hand, 
the cleavage reaction rate of Oligonucleotide 1 decreased when pH value is above 7.5 
and below 6.5. Since the variation of pH values has little effect on the stability of G-
quadruplex,111 the low efficiency of the self-cleavage reaction of Oligonucleotide 1 
could be due to certain subtle conformational change of G-quadruplex at pH beyond 
the range of 7.5 to 6.5 that disfavor the catalytic process. 































Figure 3-8 pH dependent of self-cleavage of Oligonucleotide 1 vary from 5.0 to 9.0. 
The same procedures as those for preparing samples loaded in lane 2 in Figure 3-3 
were used except that pH value of buffer in the new experiments varied. 
 
3.3.3 DNA concentration dependence 
Earlier investigations demonstrated that the conformation of G-quadruplex 
was affected by the concentration of DNA. With the aim of finding out whether the 
concentration of Oligonucleotide 1 affects our designed self-cleavage course, we 
examined Oligonucleotide 1 vary from 1 nM to 1000 nM. As shown in Figure 3-9, 
there was trace of DNA cleavage detectable when concentration of Oligonucleotide 1 
is higher than 100 nM when cleavage reactions lasted for 2 h. This most likely due to 
a different template of G-quadruplex generated before the cleavage course under high 
concentration of Oligonucleotide 1 or longer reaction time needed. 




Figure 3-9. PAGE analyses of self-cleavage of Oligonucleotide 1 in different DNA 
concentrations vary from 1 nM to 1000 nM. The same procedures as those for 
preparing samples loaded in lane 2 in Figure 3-3 were used except that concentration 
of Oligonucleotide 1 in the new experiments varied. 
 
3.3.4 Determination of rate constants of the G-quadruplex-based self-
cleavage reactions  
Time dependence of these self-cleavage reactions was also carried out in our 
studies.  As shown in Figure 3-10, the yield of the self-cleavage reactions increased 
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with the increase of reaction time and ~50% cleavage of Oligonucleotide 1 could be 
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Figure 3-10.  Time dependence of self-cleavage reaction of Oligonucleotide 1. The 
same procedures as those for preparing samples loaded in Lane 2 in Figure 3-3 were 
used except that the reactions were stopped at different time intervals. The time of 
reaction in Lanes 1, 2, 3, 4, 5 and 6 were 0, 0.5, 1, 2, 3 and 4 hours respectively. 
Similar to the actions of many cis-acting ribozymes and deoxyribozymes, self-
cleavage reaction of Oligonucleotide 1 appears to be a unimolecular process. Rate 
constants of the self-cleavage reactions of Oligonucleotide 1 were accordingly 
determined on the basis of first order kinetics112 during our investigations. The 
obtained maximum rate constant under our standard condition is 0.032 min-1 (30 °C 
pH 7.2) (Figure 3-11) which is close to those of certain hairpin ribozymes (0.1 min-1 
to 0.3 min-1) 113 in their self-cleaving courses of action. Given that the rate constant of 
spontaneous hydrolysis of DNA in the absence of catalyst is ~10-12min-1,114 
Oligonucleotide 1 produces in effects ~ 3.2 x 10110 (0.032 min-1/10-12 min-1) fold rate 
enhancement in its DNA cleavage reaction. The rate enhancement generated by 
hairpin ribozymes is only 3 x 108 (0.3 min-1/10-7 min-1) since a rate constant of 
spontaneous hydrolysis of RNA in the absence of catalyst (~10-7 min-1) 115 is much 
faster than that of DNA. In view of the extremely inert nature of phosphodiester 
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bonds of DNA as well as high degree of rate enhancement attained by 
Oligonucleotide 1, it is our opinion that this newly discovered hydrolytic self-
























Figure 3-11. Determination of observed rate constants  of Oligonucleotide 1 in its 
self-cleavage reactions. Plot of fraction of Fragment 1 versus reaction time. The 
observed rate constant (kobs = 0.032 min-1 at 30 °C) was obtained by fitting the 
corresponding data to single exponential equation F = Fmax x (1+ e-kt), where F is the 
fraction of Fragment 1 at time t. 
 
On the other hand, in order to determine whether the presence of magnesium 
ions is indeed a prerequisite for the self-cleavage process, a reaction mixture (5mM 
pH 7.0 HEPES/Histidine, 20 mM KCl and Oligonucleotide 1) containing no 
magnesium ion was examined during our investigations. As shown in Figure 3-12, 
self-cleavage reactions of Oligonucleotide 1 was only observable after the 
corresponding reaction mixtures were incubated > 42 h and yield of the self-cleavage 
reaction could reach 50.6% in 56 h (92.6% in 72 h). These observations are the 
indication that self-cleavage reaction of Oligonucleotide 1 is still capable of taking 
place in the absence of magnesium ions. 
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Figure 3-12 Time dependence of self-cleavage reaction of Oligonucleotide 1 in the 
absence of magnesium ions. The sample was kept in a mixture of 5mM pH 7.0 
HEPES/Histidine, 20 mM KCl and stopped at different time intervals varied from 24h 
to 58 h. 
 
3.3.5 Potassium ion concentration dependence 
As we discussed in Chapter 3.3.1, potassium ion is one of the preferable 
monovalent cations for stabilizing G-quadruplex structures of DNA.109, 116-118 
Potassium concentration dependence of the self-cleavage reaction was further 
examined. As shown in Figure 3-13, the yield of DNA cleavage product decreased 
when the concentration of potassium ion increased as high as 100 mM. This happened 
most likely because that high concentration of potassium ion probably could induce 
another conformation of G-quadruplex structure, which disrupts the self-cleavage 
reactions.  
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Figure 3-13.  Effect of potassium ion concentration on the self-cleavage reaction of 
Oligonucleotide 1.  The same procedures as those for preparing samples loaded in 
lane 2 in Figure 3-3 were used except that concentration of potassium chloride in the 
new experiments varied. 
 
It was discovered earlier that high concentration of sodium ion could sustain a 
different conformation of G-quadruplex structure from those in the presence of low 
concentration of Na+. Self-cleavage reactions of Oligonucleotide 1 in the presence of 
high concentration of monovalent ions were accordingly carried out. As shown in 
Figure 3-14, Oligonucleotide 1 was incubated with 80 mM of Li+, Na+, K+, Rb+ and 
Ce+ ions separately for 2 h before the self-cleavage reaction was triggered.  
Surprisingly, besides potassium, sodium and rubidium ion also generate a small 
amount of DNA cleavage product when Mg2+/Histidine complex was added. This 
happended most probably because the anti-parallel G-quadruplex structure (Figure 3-
1) needed for our self-cleavage reaction could also be sustained by high concentration 
of sodium or rubidium ion. 
  Li+     Na+     K+     Rb+     Ce+
30-mer
14-mer
   
Figure 3-14 PAGE analysis of self-cleavage of Oligonucleotide 1 in the presence of 
80 mM alkaline metal ions (Li+, Na+, K+, Rb+ and Cs+).  
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3.3.6 The formation of G-quadruplex by Oligonucleotide 1 
To verify the formation of G-quadruplex structure by Oligonucleotide 1, CD 
spectroscopic analysis on a solution containing this guanine-rich sequence was also 
carried out. As shown in Figure 3-15, this Oligonucleotide 1-containing solution 
displayed a maximum absorption at 295 nm at 34 °C, which is a characteristic sign of 
the presence of anti-paralleled G-quadruplex structures in the mixture.119-121 When the 
Oligonucleotide 1-containing solution was heated up to 90 °C, the disappearance of a 

















Figure 3-15.  CD spectroscopic analysis of Oligonucleotide 1 in the presence of K+. 
A mixture (pH 7.0) containing 5 mM HEPS, 5 mM NaCl, 5 mM KCl and 10 μM 
Oligonucleotide 1 was examined with a CD Spectropolarimeter at 34 oC (black) and 
90 oC (grey) respectively over an range of wavelengths from 220 nm to 330 nm. 
 
CD spectroscopic examination on Oligonucleotide 1-containing solutions in 
the presence of the other four monovalent ions (Li+, Na+, Rb+ and Ce+) were 
conducted during our investigations.  As it can be seen in Figure 3-16, strong positive 
peaks near 260 nm were observed when Oligonucleotide 1 was incubated with Li+, 
Na+, Rb+ and Ce+ which is the sign of presence of parallel conformation instead of 
















Figure 3-16. Comparison CD studies of Oligonucleotide 1 in the presence of 
different alkaline metal ions (Li+, Na+, K+ and Rb+ ).  
 
 
Similar phenomenon were observed when K+ was replaced by divalent ions 
(Mg2+, Ca2+, Sr2+ and Ba2+ tested), while barium ion can form major ant-parallel 
structure and consequently showed a positive peak at 295 nm (Figure 3-17). It is 
interesting that the spectroscopic data are consistent with the results generated from 


















Figure 3-17. Comparison CD studies of Oligonucleotide 1 in the presence of 
different alkaline earth metal ions (Mg2+, Ca2+, Sr2+ and Ba2+). 
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On the other hand, the CD spectrum of Oligonucleotide 1-containing solution 
in the presence of strontium ion exhibited dual peaks with equal intensity at 260 nm 
and 296 nm respectively, which indicates that this ion could sustain both parallel and 
anti-parallel conformation of G-quadruplex simultaneously, which could be the cause 
of absence of self-cleavage product when this divalent ion was used. In addition, CD 
spectrums of Oligonucleotide 1 containing certain transition metal ions such as Zn2+, 
Pb2+, Ni2+,  and Mn2+  do not give any peak with reasonable high intensity at 295 nm 
(Figure 3-18), which is also consistent with the results of our self-cleavage studies 



















Figure 3-18. Comparison CD studies of Oligonucleotide 1 in the presence of 




Self-cleavage reaction of a guanine-riched oligonucleotide (Oligonucleotide 1) 
was thoroughly studied during our investigations. It appeared that presence of 
potassium ions is a prerequisite of the self-cleavage reaction while barium ion can 
also sustain the particular G-quadruplex structure for further self-cleavage reaction. 
The results of our studies are consistent with the suggestion that G-quadruplex is the 
core structure needed for the self-cleavage process. More interestingly, our kinetic 
studies revealed that the self-cleavage rate of Oligonucleotide 1 could be as fast as 
certain hairpin ribozymes.113 In addition, the site-specific hydrolysis reaction could 
still take place when in the absence of magnesium ion as long as the corresponding 
reaction mixture was kept for 2 days. It is our hope that the results reported in the 
current studies could be helpful for searching for new G-quadruplex structures that 





Construction of Fluorescein-Tagged  
Circular G-Quadruplexes 
 
4.1 Background and Aims 
 The structural feature of G-quadruplex is a self-assembling entity of DNA 
composed of two or more stacks of G-quartets and formed either via either 
unimolecular assembling of DNA or intermolecular association.122,123 The adjustable 
nature of strand stoichiometry124-137 allows this self-assembling entity of G-
quadruplex to be formed by association of one (unimolecular), two (bimolecular) or 
four (tetramolecular) oligomeric molecules. The well-investigated examples of the 
linear oligonucleotides that constitute unimolecular, bimolecular and tetramolecular 
structures of G-quadruplex include d(G3T2AG3T2AG3T2AG3) (3.5 human telomere), 
[d(G4T4G4)]2, (Oxy-1.5) and [d(TGGGGT)]4 respectively.132, 138-144  
 It was demonstrated previously in our group145 that certain bimolecular 
structures of G-quadruplex were capable of acting as templates for directing the 
formation of circular oligonucleotides with high efficiency and sequence specificity.  
One of the intriguing aspects of these bimolecular G-quadruplex entities as templates 
was its mutual templating fashion on the scale of individual oligonucleotides in which 
one linear strand serves as a template for another.  This mutual-templating pathway 
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Figure 4-1.  Schematic representation of G-quadruplex formed unimolecularly (a), 
bimolecularly (b) and through the association of four strands of oligonucleotides (c).  
 
On the other hand, a variety of proteins have been discovered that are capable 
of binding to certain structural forms of G-quadruplexes.  Some aptamers such as an 
inhibitor of HIV integrase146 and the thrombin-binding aptamer 147 are formed through 
the utilization G-quadruplex as their structural cores.  Moreover, several G-
quadruplex-binding proteins have been identified over the past ten years such as rat 
liver proteins uqTBP25.148 On the basis of earlier discoveries,146-151 construction of 
unimolecularly circular G-quadruplexes tagged with fluorescent molecules as 
molecular probes was accordingly set up as one of our long-term research objectives.  
One of the advantages in our selection of circular oligonucleotides as diagnostic 
probes is their complete resistance to exonuclease hydrolysis, a property resulted from 
the absence of open terminus within their structures.152 In addition, the structured 
DNA composed of circular sequence often possesses a higher melting point than those 
constituted of linear components while higher stability is always preferred in the 
design of molecular probes.153 Therefore, we anticipate that the fluorescence-labeled 
circularly unimolecualr G-quadruplexes could act as useful probes for identifying new 
types of enzymes and other functional proteins correlated with G-quadruplex in vivo 
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and for elucidating the binding patterns between G-quadruplex and its corresponding 
binding proteins. The outcomes of our investigation on design, synthesis and 
characterization of the particular circular oligonucleotides on the template basis of G-
quadruplex structures are discussed in the following sections of this chapter. 
4.2 Construction of Circular Oligonucleotides on the Basis of 
Unimolecular G-Quadruplex 
4.2.1 Design and Synthesis of Circular Oligonucleotides on the Basis of 
Unimolecular G-Quadruplex 
In the initial step, exploration of the feasibility of constructing unimolecular 
G-quadruplex without a fluorescence tag (f in Figure 4-2) was carried out. As 
expected, it is demonstrated that certain unimolecularly circular G-quadruplexes can 
indeed be attained from linear precursors through chemical ligation reactions.  In 
addition, in consideration of the fact that several new proteins discovered during the 
past few years facilitate either the formation of linear unimolecular G-quadruplex or 
disintegration of it,154-160 it is our anticipation that the unimolecularly circular G-
quadruplexes attained in our studies (f in Figure 4-2) could be a unique tool for 
unveiling the winding and resolving mechanisms of G-quadruplex mediated by these 






































Figure 4-2.  Diagrammatic illustration of our strategy for constructing unimolecularly 
circular G-quadruplex through chemical ligation.  
 
A unimolecular G-quadruplex template was selected (g in Figure 4-3) rather 
than its bimolecular counterpart (i) as the synthetic target in our strategy.  It is because 
that the concentrations of diagnostic molecules in many practical applications are very 
low161, 162 while bimolecular complexes (i), once dissociated into the corresponding 
unimolecular components (j), might not readily go back to its original state at a very 
low concentration due to kinetic unfavorableness. In addition, a fluorescence-tagged 
bimolecular G-quadruplex can in theory possess two isomeric forms (i and k) while 
one of them (k) may not be suitable as a molecular probe because of the presence of 
fluorescence tags at both ends of its columnar structure that prevent the approach of 
G-quadruplex-interacting proteins.  This co-existence of two isomeric forms could 
decrease the efficiency of bimolecular G-quadruplexes as molecular probes in 
practical application.  In contrast, unimolecular G-quadruplex could, even if it is 
denatured occasionally, readily return to its original folding state as the result of 
kinetic favorableness.  It consequently appears that selection of unimolecular G-
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Figure 4-3.  Possible folding patterns of certain fluorescence-tagged circular G-
quadruplexes. 
m nl  
Figure 4-4.  Illustration of different loop geometries possessed by unimolecular G-
quadruplexes. 
 
The loops in a unimolecular G-quadruplex can in general be connected in 
three different ways (Figure 4-4).   It appears that the only conformation that can be 
utilized to synthesize circular oligonucleotides is the one with its loops connected in 
adjacent-adjacent-adjacent fashion (l in Figure 4-4).  Figure 4-2 accordingly 
illustrates our strategy for manipulating the unimolecular entity of G-quadruplex to 
facilitate the construction of guanine-rich circular oligonucleotides.  A linear 
sequence, 5’ GG(TTTTGGGG)3TTTTGG3’ (Sequence 1), was selected as the 
precursor of our circularization reaction.  It is anticipated that under certain conditions 
this linear oligonucleotide would self-assemble into a desired unimolecular complex, 
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within which its two termini are forced to align in a proximal position guided through 
reversed Watson-Crick interaction.163 Once this self-assembling entity (e in Figure 4-
2) is generated, subsequent chemical ligation reaction between the two open termini 
would lead to a desired circular G-quadruplex constituted of a single strand of 
oligonucleotide. 
Sequence 1 was accrodingly incubated in a pH 6.0 buffer to allow the desired 
structure of G-quadruplex to generate (d to e in Figure 4-2).  The 5’ terminal 
phosphate within the unimolecular complex was following activated by the addition 
of N-cyanoimidazole to facilitate the formation of a phosphodiester bond with its 
adjacent 3’ hydroxyl group (e to f in Figure 4-2).  As shown in Figure 4-5, a new 
product (Lane 9) was generated from this ligation reaction with its rate of mobility 
shift slower than that of Sequence 1 (Lane 1).  It was demonstrated earlier by Wang 
and Kool164 that a 34-mer circular oligonucleotide moved slower than that of its 
corresponding linear precursor.  Based on this information, the newly formed product 
from our ligation reaction was identified tentatively as the circular oligonucleotide 
generated from its corresponding linear precursor, Sequence 1.  The yields of this 
ligation reactions was found to be dependent on reaction time: circularization of the 
linear precursor proceeded in 13, 29, 42, 59, 67 and 71% yield when the 
corresponding reactions continued for 5 (Lane 4), 30 (Lane 5), 60 (Lane 6), 120 (Lane 
7), 240 (Lane 8) and 360 min (Lane 9) respectively and the overall yield of the 
ligation reaction is 39% after gel purification. 
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Figure 4-5. Construction of unimolecularly circular oligonucleotides on the template 
basis of G-quadruplex and time course of the ligation reaction (refer to Chapter 6 for 
Chemical ligation reactions protocols). The reaction times for these ligation reactions 
were 0 (Lane 3), 5 (Lane 4), 30 (Lane 5), 60 (Lane 6), 120 (Lane 7), 240 (Lane 8) and 
360 min (Lane 9) respectively.  Lane 1: Sequence 1 alone.  Lane 2: same reaction as 
the one loaded in Lane 9 except for the absence of N-cyanoimidazole.  Lane 10: the 
45-mer of  5’T3CGT2CGTGCT2GCT3GCTCT2G3T2AG5T2AG2T43’  as a molecular 
weight marker. 
 
It should be  noticed that the circular oligonucleotide possessing three 
guanines in a row in its sequence， <TTAGGGTTAGGGTTAGGGTTAGGG>， can 
not be synthesized using the same methodology as discussed above starting from a 
linear precursor of 5’ GGTTAGGGTTAGGGTTAGGGTTAG 3’ or 5’ 
GTTAGGGTTAGGGTTAGGGTTAGG 3’ while these two linear oligonucleotides are 
closely correlated with the sequences of telomeres of higher organisms.  In addition, 
the type of circular oligonucleotides synthesized in our studies can form only the 
structure of G-quadruplex with its loop connected in an adjacent-adjacent-adjacent 
fashion (l in Figure 4-4).  The G-quadruplex of biological importance in many cases 
are, however, the ones exhibiting parallel orientation (c in Figure 4-1) or possessing 
loops connected in adjacent-diagonal-adjacent manner (m in Figure 4-4)165-171 while 
the structural feature possessing adjacent-adjacent-adjacent loops (l) are presumably 
present only in a limited number of biological processes.172, 173 These disadvantages 
could accordingly prevent the use of unimolecularly circular G-quadruplexes in a 
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wider range of practical application. 
4.2.2 Confirmation of Circular Nature of Our Ligation Product 
Exonuclease VII is an exonuclease that hydrolyzes nucleotides from both 3’ 
and 5’ ends of single-stranded linear sequence of deoxyribonucleic acids. Circular 
oligonucleotides are known to resist the degradation by this enzyme153, 174 due to the 
absence of open termini within their structures.  In order to confirm the circular nature 
of its phosphate-sugar backbones, the newly formed product from our ligation 
reaction was purified via denaturing polyacrylamide gel electrophoresis and then 
hydrolyzed by this exonuclease.   As shown in Figure 4-6, there was absent of 
degradation product observable from the reaction of our identified circular product 
with exonuclease VII (Lane 4).  As a positive control, the hydrolysis reaction of 
Sequence 1 with exonuclease VII was also carried out, which consequently led to 
lower molecular-weight products in quantitative yield (Lane 2).  The complete 
resistance of our ligation product to the hydrolysis by this exonuclease should be 




Figure 4-6.  Hydrolysis of the identified circular products by exonuclease.  Lane 1: 
Sequence 1 alone.  Lane 2: Sequence 1 after treatment with 20 units of exonuclease 
VII at 37 °C for 2 h. Lane 3: the identified circular products alone.  Lane 4: the 
identified circular product after treatment with 20 units of exonuclease VII at 37 °C 
for 2 h. 
 
 
Figure 4-7.  Partial hydrolysis of the identified circular products by DNAse I.  Lane 1: 
Sequence 1 alone. Lane 2: the identified circular products alone.  Lane 3: the 




  Previous gel electrophoretic studies by others164,174 revealed that partially 
randomized hydrolysis of circular sequences of oligonucleotides resulted in a new 
major band with its rate of mobility shift nearly equal to that of its linear precursor.  
The reason leading to this observation is that cleavage of any of the phosphodiester 
bonds within a circular structure will give rise to the corresponding linear products 
possessing identical molecular weight.174 With the aim of further confirming the 
circular nature of our ligation product, partial hydrolysis tests were carried out during 
our investigation through the use of DNAse I, an enzyme that hydrolyze both single 
and duplex forms of DNA in a randomized pattern.  As shown in Figure 4-7, a major 
band was observed upon partial hydrolysis of our ligation product that exhibited the 
same rate of mobility shift as that of its linear precursor (Lane 3).  In addition, there 
was absent of intermediate bands between our ligation product (higher band in Lane 3) 
and the major band produced from it, which was the characteristic pattern of 
randomized partial hydrolysis of circular oligonucleotides by enzyme or chemicals.164, 
174 
4.2.3 Conformation Dependence of the Circularization Reactions 
If the designed self-assembly of G-quadruplex (e in Figure 4-2) is indeed an 
intermediate structure of our ligation reactions, any alteration from this conformation 
should have an effect on our circularization courses.  In order to examine the effect of 
this conformation dependency, four new sequences were designed during our 
investigations in which one, two, three or four non-guanine nucleotides appeared at 
their 5’ or 3’ end.  As shown in Figure 4-8, none of the four mismatched sequences 
exhibited any observable amount of circularization product (Lanes 3 to 10) under the 
same reaction condition as the one designed for Sequence 1 (Lane 2).  These 
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experimental results indicated that a single-base variation led to a distorted 
conformation of G-quadruplex that was consequently incapable of sustaining correct 
proximity between the 5’ and 3’ termini of the same sequence as required for further 
chemical ligation reaction. 
 
Figure 4-8.  Effect of mismatched sequences on the circularization reaction.  Ligation 
reactions were carried out in the same way as the one loaded in Lane 9 in Figure 4-5 
except for replacing Sequence 1 with the corresponding mismatched sequences.  Lane 
1: Sequence 1 alone; Lane 2: reaction mixture of Sequence 1; Lane 3: mis-1 ( 5’ 
TGT4G4T4G4T4G4T4G2 3’) alone;  Lane 4: reaction mixture of mis-1; Lane 5: mis-2 
( 5’ TGT4G4T4G4T4G4T4GT  3’) alone; Lane 6: reaction mixture of mis-2; Lane 7: 
mis-3 ( 5’ TTT4G4T4G4T4G4T4GT 3’) alone;  Lane 8: reaction mixture of mis-3; Lane 
9: mis-4 ( 5’ TTT4G4T4G4T4G4T4TT 3’) alone; Lane 10: reaction mixture of mis-4. 
 In order to further probe the effect of sequence variation on our circularization 
reaction, four additional linear oligonucleotides were selected that were shorter than 
Sequence 1 by one (rec-1), two (rec-2), three (rec-3) or four (rec-4 in Figure 4-9) 
nucleotide units.  Our expectation from the design of these new sequences was that G-
quadruplex, once it was formed from rec-1, rec-2, rec-3 or rec-4, would possess 
recessive ends in the middle of its columnar structure.  As shown in Figure 4-7, a 
small amount of circularization product was generated when the ligation reaction 
began with rec-1 (Lane 4) while there was absent of circular product observable in the 
reactions where the sequences of rec-2 (Lane 6 in Figure 4-9), rec-3 (Lane 8) and rec-
4 (Lane 10) were used as reactants.  These observations could be the indication that a 
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proper structural feature of G-quadruplex can still be generated from a linear 
oligonucleotide shorter than Sequence 1 by one nucleotide unit, but not by the others 
that are two or more nucleotide units shorter.   
 
Figure 4-9.  Effect of recessive sequences on the circularization reaction.  Reactions 
were carried out in the same way as the one loaded in Lane 9 in Figure 4-5 except for 
replacing Sequence 1 with the corresponding recessive sequences.  Lane 1: Sequence 
1 alone; Lane 2: reaction mixture of Sequence 1. Lane 3: rec-1 ( 5’ 
GT4G4T4G4T4G4T4G2 3’, 31-mer) alone.  Lane 4: reaction mixture of rec-1; Lane 5: 
rec-2 ( 5’ T4G4T4G4T4G4T4G2 3’, 30-mer) alone; Lane 6: reaction mixture of rec-2; 
Lane 7: rec-3 (5’ T4G4T4G4T4G4T4G 3’, 29-mer) alone ; Lane 8: reaction mixture of 
rec-3; Lane 9: rec-4 ( 5’ T4G4T4G4T4G4T4 3’, 28-mer) alone ; Lane 10: reaction 
mixture of rec-4. 
4.2.4 Loop-Size Dependence of Our Circularization Reactions 
One of the distinctive features of G-quadruplex in structure is its possession of 
connecting loops that link the guanine tracts within the unimolecular and bimolecular 
complexes of G-quadruplexes.175 The sequences of d(G4TnG4) (n ≥2), for example, 
are capable of forming looped quartet structures whose stabilities increase with the 
increase in the number of intervening thymine residues within their loops.132, 177-179 
When a single thymine nucleotide is present between the guanine tracts within a 
linear oligonucleotide such as d(G4TG4), however, this guanine-rich sequence can 
only adopt parallel four stranded structure rather than an antiparalell looped dimeric 
complex.177 This took place because the backbone of a single thymine residue is too 
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short to span over the two edges of a G-quadruplex structure.  In consideration of the 
fact that connecting loops play significant roles in the formation and stabilization of 
unimolecular G-quadruplex,132, 177-179 loop-size dependency of our circularization 
reaction was thus examined during our investigation.  Five new sequences were 
accordingly designed in our studies, in which the numbers of thymine nucleotide 
between guanine tracts are one (lp-1 in Figure 4-10), two (lp-2), three (lp-3), four (lp-
4) and five (lp-5) respectively. As shown in Figure 4-10, our circularization reaction 
starting with lp-2 (Lane 4), lp-3 (Lane 6), lp-4 (Lane 8) and lp-5 (Lane 10 in Figure 
4-10) proceeded in 31, 20, 72 and 60% yield respectively.  Conversely there was 
absent of circularization product observable when the ligation reaction began with lp-
1 (Lane 2). These results were consistent with the early suggestion177 that at least two 
thymine nucleotides within the intervening loops are needed to sustain a stable fold-
back structure of G-quadruplex.   
 
Figure 4-10.  Effect of loop size on the circularization reaction.  Reactions were 
carried out in the same way as the one loaded in Lane 9 in Figure 4-5 except for 
replacing Sequence 1 with lp-1 (5’ G2TG4TG4TG4TG2 3’), lp-2 (5’ 
G2T2G4T2G4T2G4T2G2 3’), lp-3 (5’ G2T3G4T3G4T3G4T3G2 3’) and lp-5 (5’ 
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G2T5G4T5G4T5G4T5G2 3’) respectively.  Lane 1: lp-1 alone; Lane 2: reaction mixture 
of lp-1; Lane 3: lp-2 alone; Lane 4: reaction mixture of lp-2; Lane 5: lp-3 alone; Lane 
6: reaction mixture of lp-3; Lane 7: Sequence 1 alone; Lane 8: reaction mixture of 
Sequence 1; Lane 9: lp-5 alone; Lane 10: reaction mixture of lp-5. 
4.2.5 Alkali-Ion Dependence of Our Circularization Course 
Selective interaction with cations that fit well in the cavities formed by the 
stacking of guanine tetrads is a distinguishable characteristic of G-quadruplex from 
any other structural features of nucleic acids. In the alkali series, the order of ions 
preferred by G-quartet is K+>>Na+>Rb+>Cs+>Li+.175 With the intention of knowing 
whether alkali ion affects our circularization course, the efficiency of our 
circularization course in the presence of these ions was examined during our 
investigation.  As shown in Figure 4-11, there was absent of circular product 
observable when lithium (Lane 2), sodium (Lane 3), rubidium (Lane 4) and cesium 
ions (Lane 5) were used to facilitate the formation of G-quadruplex structures.  This 
took place most likely because these alkali ions might not be able to sustain a stable 
structure of G-quadruplex as potassium ion does under our standard condition for 
chemical ligation reactions. 
 
Figure 4-11.  Effect of alkali ions on the circularization reaction.  Lane 1. same as 
lane 9 in Figure 4-5.  Lanes 2 to 5: Reactions were carried out in the same way as the 
one loaded in Lane 9 in Figure 4-5 except for replacing KCl with 100 mM of LiCl 
(lane 2), NaCl (lane 3), RbCl (lane 4) and CsCl (lane 5) respectively.  
 70
4.2.6 pH Dependence of the Designed Ligation Reactions 
The effect of pH values on our circularization course was examined during our 
investigation in the range from 5.5 to 7.5.   As shown in Figure 4-12, the efficiency of 
our ligation reactions decreased with the increase of pH values of the corresponding 
buffer solutions.  These ligation reactions proceeded in 75, 78, 71, 49, 9 and 1% yield 
respectively at pH 5.5 (Lane 2), 6.0 (Lane 3), 6.5 (Lane 4), 7.0 (Lane 5) and 7.5 (Lane 
6).  Earlier CD spectroscopic analysis177 revealed that variation of pH values of the 
corresponding buffer solutions ranged from 5 to 8 alone exhibited little effect on the 
stability of G-quadruplex.  The relative low efficiency of our ligation reaction at 
higher pH values (Lanes 5 and 6) should be attributed to the fast decomposition of N-
cyanoimidazole, the chemical agent required for the ligation reaction, under basic 
conditions. 
 
Figure 4-12.  pH dependency of the circularization reaction.  Reactions were carried 
out in the same way as the one loaded in Lane 9 in Figure 4-5 except for that pH of 
the buffer solutions were 5.5 (lane 2),  6.0 (lane 3), 6.5 (lane 4), 7.0 (lane 5), and 7.5 
(lane 6) respectively; lane 1: Sequence 1 alone. 
4.2.7 Potassium Ion-Concentration Dependence of Our Ligation Reaction 
Possession of cations by the structural feature of G-quartet as a part of its 
structure determines that the formation of G-quadruplex from its precursor of 
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unstructured sequences is an ion-concentration dependent process.  Earlier capillary 
electrophoresis studies128 revealed that G-quadruplex was not observable in the 
absence of cations while the amount of this tetraplex structure increased with the 
increase of the concentration of potassium ion. When the concentration of potassium 
chloride reached up to 100 mM,128 single stranded form of DNA was converted to G-
quadruplex structures completely.  With the aim of finding out whether our designed 
unimolecular structure of G-quadruplex (e in Figure 4-2) is affected by the variation 
of ion concentration, our ligation reaction in the presence of different amount of 
potassium ion was accordingly examined during our investigation.  As shown in 
Figure 4-13, the efficiency of the circularization reactions increased with the increase 
of potassium ion concentration (Lanes 2 to 8) and the ligation product in over 50% 
yield was obtained when potassium ion concentration was kept at 100 mM (Lane 2).  
These results were consistent with the early suggestion that there is equilibrium 
between the unstructured linear sequence and G-quadruplex structures in which a 
higher ion concentration favors the formation of structured DNA.176 
 
Figure 4-13.  Effect of potassium-ion concentration on the circularization reaction.  
Ligation reactions were carried out in the same way as the one loaded in Lane 9 in 
Figure 4-5 except for that the concentration of potassium chloride was kept at 200 
mM (lane 1), 100 mM (lane 2), 40 mM (lane 3), 20 mM (lane 4), 10 mM (lane 5), 4 
mM (lane 6), 2 mM (lane 7), 1 mM (lane 8), 0.2 mM (lane 9), 0 mM (lane 10) instead. 
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4.2.8 Verification of Formation of G-Quadruplex from Newly 
Synthesized Circular Oligonucleotides 
With the aim of verifying that the structural feature of G-quadruplex could 
indeed be generated by the newly synthesized circular oligonucleotides, certain CD 
spectroscopic examinations were carried out on the corresponding ligation products.  
As shown in Figure 4-14, the CD spectrum of this circular oligonucleotide displayed 
a low amplitude peak near 275 nm in the absence of added salt.  In the presence of 
potassium chloride, however, this circular oligonucleotide exhibited a spectrum 
characterized by positive maxima near 293 nm and a negative minimum near 265 nm, 
which are the typical features of formation of G-quadruplex from random 
conformations of oligonucleotides.   The results shown in Figure 4-14 are accordingly 
consistent with the suggestion that a guanine-rich circular oligonucleotide, like its 
linear counterpart, is capable of forming G-quadruplex in the presence of potassium 
chloride.   









Wavelength [nm]  
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Figure 4-14.  CD spectra of circular oligonucleotides of 
<GGTTTTGGGGTTTTGGGGTTTTGGGGTTTTGG> (20 µM) in 10 mM Tris·HCl 
buffer (pH 7.0) containing  0 mM (——), 0.1 mM (— — —), 0.2 mM (– – – – – –), 2 
mM (– — –  —) and 20 mM (– – –—– – –) KCl respectively.   
 
Table 4-1. Sequences of oligonucleotides used in the current study. 
 





4.3 Construction of Fluorescein-Tagged Circular Oligonucleotides  
4.3.1 Design and Synthesis of Fluorescein-Tagged Circular 
Oligonucleotides  
After verify the feasibility of constructing the unimolecular G-quadruplex 
without a fluorescein tag, a fluorescein molecule was labeled on Sequence 1 for 
further examinations. Figure 4-15 describes our approach of synthesis of circular G-
quadruplex tagged with a fluorescein moiety.   Sequence 1 (Figure 4-15) is a linear 
32-mer oligonucleotide containing a fluorescein moiety covalently linked to the 
carbon-5 of a thymine within the sequence.  It was tentatively assumed in the early 
stage of these studies that this fluorescent moiety had little effect on the formation G-
quadruplex since the covalently modified thymine would presumably appear in the 
loop region of G-quadruplex.  Accordingly, a stock solution of Sequence 1 (2µM) in a 
buffer solution containing 100 mM MES (pH 6.0) and 100 mM KCl was heated to 
100 °C and kept at the same temperature for three minutes followed by cooling the 
mixture to 25 °C over a time period of two hours.  A reaction mixture containing 1 
μM of annealed Sequence 1, 100 mM MES (pH 6.0), 100 mM KCl, 10 mM MnCl2 
and 10 mM N-cyanoimidazole in a total volume of 20 μL were then prepared and 
incubated at 25 °C for 24 hours.  The reaction was next terminated by the addition of 






































(b) (c)  
Figure 4-15. Schematic representation of our synthetic route toward fluorecein-
labeled circular G-quadruplex.  
As shown on the autoradiogram in Figure 4-16, a new product was formed 
from our designed ligation reaction with its mobility shift slower than that of 
Sequence 1 (upper band of lane 5), which was presumably the desired fluorecein-
labeled circular G-quadruplex (c in Figure 4-15).  As controls, circularization 
reactions of a non-fluorecein- labeled oligonucleotide 
(5’pGGTTTTGGGGTTTTGGGGTTTTGGGGTTTTGG 3’, Sequence 2) were also 
carried out (lanes 2) under the same condition as the one for the sample loaded into 
lanes 5 in Figure 4-16. As it can be seen on this autoradiogram, the circularization 
product of non-fluorecein-tagged oligonucleotide (Lane 2) possessed a faster rate of 
mobility shift than that of fluorecein-tagged oligonucleotide (Lane 5).  The mobility 
shift difference between these two circular products can be attributed to the 
possession of an extra fluorecein moiety within the fluorescein-tagged circular 
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product (c in Figure 4-15) in our designed reaction. 
 
Figure 4-16.  Electrophoretic analysis of fluorecein-labeled circular G-quadruplex. 
Lane 1: Sequence 2 alone. Lane 2: Same reaction as the one loaded in Lane 5 except 
for replacing Sequence 1 with Sequence 2. Lane 3: same reaction as the loaded in 
Lane 2 except for the absence of N-cyanoimidazole. Lane 4: Sequence 1 alone. Lane 
5: a reaction mixture containing 1 μM annealed Sequence 1, 100 mM MES (pH 6.0), 
100 mM KCl, 10 mM MnCl2 and 10 mM N-cyanoimidazole in a total volume of 20 
μL was incubated at 25 °C for 24 hours. Lane 6: same reaction as the loaded in Lane 5 
except for the absence of N-cyanoimidazole. Lane 7: the 48-mer of 
5’T3CGT2CGTGCT2GCT3GCT3C2T2G3T2AG5T2AG2T4 3’ as a molecular weight 
marker. 
 
4.3.2 Structural Verification of Fluorescein-Tagged Circular 
Oligonucleotides  
With the aim of verifying that circularization of fluorescein-tagged circular 
oligonucleotides indeed took place, the newly formed product (upper band in Lane 5 
of Figure 4-16) was purified and further digested with exonuclease VII (an 
exodeoxyribonuclease that hydrolyzes linear DNA from both 3’ and 5’ termini).  Due 
to the absence of open ends in its structure, fluorecein-labeled circular oligonucleotide 
should in theory resist the degradation by this exonuclease. 180, 181 As shown in Figure 
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4-17, the newly formed product in the circularization reaction completely resisted the 
hydrolysis by exonuclease VII (Lane 4) as expected. In contrast, a linear sequence 
(Sequence 2) was hydrolyzed to completion by exonuclease VII (lane 2) under the 
same reaction condition.  
In addition to this test of degradation by exodeoxyribonuclease, hydrolysis of 
the fluorecien-labeled circular G-quadruplex using DNAse I was carried out.  DNAse 
I is an endonuclease hydrolyzing both single and duplex forms of DNA in a 
randomized pattern. As shown in Figure 4-18, a major band was observed upon 
partial hydrolysis of our fluorescein-labeled circular product by the endonuclease. 
This degradation product displayed the same rate of mobility shift as that of its linear 
precursor (Lane 3), which was the characteristic pattern of randomized partial 
hydrolysis of circular oligonucleotides by enzyme or chemicals.182, 183 The results of 
both exonuclease and endonuclease hydrolysis in these studies are consistent with the 
suggestion that the newly formed product in our designed reaction is indeed circular 
in its backbone structure.  
 
Figure 4-17. Hydrolysis of fluorecein-labeled circular products by exonuclease VII.  
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Lane 1: Sequence 1 alone.  Lane 2: Sequence 1 after treatment with 20 units of 
exonuclease VII at 37 °C for 2 h. Lane 3: our designed fluorecein-labeled circular G-
quadruplex alone.  Lane 4: our designed fluorecein-labeled circular G-quadruplex 
after treatment with 20 units of exonuclease VII at 37 °C for 2 h. 
 
 
Figure 4-18. Partial hydrolysis of the fluorecein-labeled circular products by DNAse I.  
Lane 1: Sequence 1 alone. Lane 2: our designed fluorecein-labeled circular G-
quadruplex alone.  Lane 3: our designed fluorecein-labeled circular G-quadruplex 
after treatment with 10 units of DNAse I at 25 °C for 30 min. 
 
4.3.3 Fluorescence Measurement of Fluorescein-Tagged Circular G-
Quadruplex 
It was well established in the past that when fluorescein-labeled 
oligonucleotides were under fluorescence spectroscopic examination, the 
corresponding emission is readily detectable.184 In order to verify that the molecular 
moiety of fluorescein was indeed present in our designed circular G-quadruplex, 
fluorescence spectroscopic measurements were carried out on the corresponding 
samples of oligonucleotides. As shown in Figure 4-19, our designed circular G-
quadruplex exhibited the emission maximum at 520 nm when the wavelength of 
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excitation was set at 495nm while a non-fluorescence-tagged oligonucleotide 
(Sequence 2) displayed no emission in the corresponding range of wavelength. These 
results are the indication that fluorescein moiety is a part of the molecular entity of 
our designed circular G-quadruplex. 













Figure 4-19. Fluorescence emission spectra of fluorescein-labeled circular G-
quadruplex (a) and non-fluorescein-labeled linear oligonucleotide, Sequence 2 (b).  
Samples in the measurements contained 1 μM oligonucleotides and 10 mM Tris 
buffer (pH 7.0) and were examined at 20 °C with excitation set at 495 nm 
 
 
4.4 Conclusions  
This work demonstrates that certain unimolecularly circular G-quadruplexes 
can indeed be attained on the template basis of G-quadruplex through chemical 
ligation reactions.  These circularization courses are highly effective and sequence 
specific under our standard reaction conditions.  The circular structure of G-
quadruplex possessing two, three, four or five thymine nucleotides in its intervening 
loops is readily achievable while the linear sequences possessing a single thymine 
nucleotide between its guanine tracts is not a proper precursor for our circularization 
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reaction.   
In addition, it was demonstrated in our studies that the presence of potassium 
ion is the prerequisite for the synthesis of circular G-quadruplex while such circular 
sturcutres could not be obtained in the presence of other alkali ions such as Na+ and 
Li+. Moreover, our further examinations showed that this circularization course can be 
affected by other factors such as pH values of the corresponding buffer solutions as 
well as the concentration of potassium ions.  
On the basis of our successful synthesis of circular G-quadruplex, fluorescein-
labeled circular G-quadruplex was also accomplished during our studies. This newly 
obtained fluorescein-tagged circular product resisted the hydrolysis by an exonuclease 
as anticipated. In addition, fluorescence spectroscopic analysis revealed that 
fluorecein moiety was indeed associated with the designed G-quadruplex.   
It is anticipated that the unimolecularly circular G-quadruplex with a 
fluorescein tag could act as useful molecular probes for identifying new types of 
enzymes and other functional proteins correlated with G-quadruplex in vivo. In 
addition, it is our hope that the newly designed fluorescein-tagged G-quadruplex 
could be utilized for tracing the location and distribution of G-quadruplex-binding 
proteins in living cells through detection of the signal of fluorecein covalently linked 




 Chapter 5 
Development of New Oligonucleotides-Based 
Topoisomerase I Inhibitors 
 
5.1 Background and Aims 
5.1.1 DNA Topoisomerases  
In eukaryotic cells, double helical DNA is supercoiled and condensed into 
chromosomes by wrapping tightly around histones.185, 186 For a number of essential 
cellular processes, the information stored in DNA must be accessed, thus the two 
strands of the helix have to be separated. In addition, during transcription, the 
translocating RNA polymerase generates supercoiling tension in the DNA which also 
needs to be relaxed. Besides, replications of two complementary DNA strand, or 
recombination between DNA duplex can generate chromosomal knots or catenanes.187 
Failure to solve these topological problems would cause chromosomal breakage or 
even severer consequence for cell viability.  
DNA Topoisomerases, the marvelous molecular machines designed by nature, 
happen to be such an essential class of enzymes that can overcome the above 
topological problems generated by multiple cellular processes.188 These enzymes 
catalyze topological rearrangements of DNA through sequential single-stranded 
breakage, strand free rotation and rejoining of phosphodiester backbone of DNA, 
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which removes knots and catenanes generated by metabolic processes in vivo.189  
 
Figure 5-1. Superhelical tension generated by DNA unwinding and resolved by DNA 
topoisomerases.1 
 
Topoisomerases can be grouped into two types, and each of them has a unique 
structure and functionality. The enzymes that cleave only one strand of the duplex 
DNA are defined as type I topoisomerases, which can be further classified as either 
type IA subfamily members in which the protein links to a 5’ phosphate or type IB 
subfamily members in which the protein attaches to a 3’ phosphate. Topoisomerases 




Figure 5-2. Type I and Type II DNA topoisomerases185 
5.1.2 Mode of Action of DNA Topoisomerase I 
The DNA relaxation activity of DNA topoisomerase I does not require ATP or 
Mg2+. They bind only to double stranded DNA and change the linking number of 
DNA by one in each cycle. The relaxation of supercoiled DNA by topoisomerase I 
involves these essential steps: DNA binding (a) , nucleophilic attack by the active site 
tyrosine leads to cleavage of the DNA backbone (b), single strand rotation (c), 
relegation of phosphate backbone to restore the continuity of DNA (d) and finally 
released from DNA (e and f). Initially, DNA topoisomerase I binds to double-stranded 
DNA and covers a region of about 20 bp. It then cleaves one of the double helical 
DNA strands by launching a nucleophilic attack on the 3’ end scissile phosphoryl of 
the DNA backbone through a reversible trans- esterification reaction. The cleavage 
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action results in a covalent attachment of the 3’-phosphate onto the protein and a free 
5’-hydroxyl end. Besides, the cleavage leads to the formation of a transient covalent 
topoisomerase I - DNA intermediate. Subsequently, the tension within the supercoiled 
DNA drives a controlled rotation of the free 5’ end to achieve a low energy 
conformation and hence relaxed form of DNA. The enzyme subsequently religates the 
5’-hydroxyl termini of the nicked strand and dissociates itself from the relaxed 
DNA.186-189   
 
Figure 5-3. Mode of action of DNA topoisomerase I 186 
The above mentioned pathway of action of topoisomerase I is known as the 
swivel mechanism, which is specific to topoisomerase IB, the class of enzyme that 
human topoisomerase I belongs to. Other classes of topoisomerases include 
topoisomerase IA, which employs the strand passage mechanism of relaxing supercoil, 
while topoisomerase IIα and topoisomerase IIβ cleaves two strands of DNA in its 
mode of action.  
 85
5.1.3 Topoisomerase I inhibitors 
Growing interest in toposiomerases not only attributes to their ability of 
managing DNA topology, but also to their importance in pharmacology and clinical 
medicine. Topoisomerase I has been found to be highly abundant in fast proliferating 
tumor cells than in normal tissue188, 189 and identified as a molecular target of several 
anticancer agents. Camptothecin, irinotecan and topotecan are the examples of 
topoisomerase I inhibitors that are currently used in the clinical treatment of cancers 
(Figure 5-4).190   
Camptothecin was the first specific topoisomerase I inhibitor discovered and 
was first identified as a drug with potential antitumor activity in 1966.190 It was 
originally isolated from the Chinese tree Camptotheca acuminate. Irinotecan and 
topotecan are the derivatives of camptothecin.190 In the process of actions, these 
anticancer agents bind to a transient topoisomerase I-DNA covalent complex and 
inhibit the resealing of a single-strand nick that the enzyme creates to relieve 
superhelical tension in duplex DNA, functioning as poisons of the enzyme. Although 
these drugs exhibit anti-tumor activity, they have some undesirable side effects. For 
example, irinotecan causes symptoms such as cholinergic-like syndrome, delayed 
onset diarrhea, neutropenia, nausea and vomiting, fatigue and alopecia.190   
















Figure 5-4.  Chemical structures of Camptothecin, Topotecan and irinotecan. 
Besides these natural products and synthetic organic compounds identified as 
inhibitors of DNA topoisomerase I, certain oligonucleotides-based inhibitors were 
designed earlier in our laboratory that displayed high inhibitory potency on the 
activity of this DNA relaxing enzyme.191 In order to explore new oligonucleotides for 
topoisomerase I inhibitors, certain particular structural assemblies of oligonucleotides 
were designed and synthesized during my graduate studies. The corresponding results 
are discussed in the following sections of this chapter.  
5.2 Construction of C3-spacer-Containing Circular Oligonucleotides 
as Topoisomerase I Inhibitors 
5.2.1 General Design Strategy  
Due to their possession of mismatched base pairs,198 the early designed 
oligonucleotide inhibitors reported in our previous studies could be vulnerable to the 
degradation by some DNA repair enzymes. With the aim of developing 
oligonucleotide inhibitors that could resist the hydrolysis by mismatch and nick-
resolving DNA repair enzymes, we have very recently introduced C3-spacer (-CH2-
CH2-CH2-) modifications199 into the corresponding oligonucleotide structures. 
Figure 5-5 shows a dumbbell-shaped circular oligonucleotide200 
(Oligonucleotide 1) designed during our recent studies, which possesses two 
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“extraordinarily thermostable hairpins”201 at both termini of its duplex structure. It is 
anticipated that introduction of these two hairpins to Oligonucleotide 1 could lead to 
an increase of thermal stability of the dumbbell-shaped structure and prevent itself 
from hydrolysis by exonucleases.201 In addition, it has been well established in the 
past that during the strand scission and religation process, Topo I forms transitorily a 
covalent bond with the 3’ end of DNA fragment and holds the 5’ end of the second 
fragment through physical interaction. 192-197, 202 
Taking advantage of the fragile interacting fashion between Topo I and the 
resultant 5’ end of DNA, a C3-spacer was introduced into the dumbbell-shaped 
structure near the Topo I cutting site of Oligonucleotide 1 in order to generate an 
irreversible inhibition to the nuclear enzyme. It was our expectation that once Topo I 
would bind to Oligonucleotide 1 and further cause a strand scission at its cutting 
site203 (Figure 5-6), the religation reaction between the cut fragments might not 
readily take place.  This could happen because the presence of C3-spacer in the 
dumbbell-shaped structure might lead to a free dissociation of the corresponding 
trinucleotide (5’ GGA, see Figure 5-6) from Topo I and its complementary stretch, 
thus leading to chemically irreversible damage to the enzyme.204, 205 In addition, it was 
anticipated that Oligonucleotide 1 could resist the hydrolysis by some mismatch- and 
nick-resolving DNA repair enzymes since introduction of C3-space would not lead to 
any base mismatches or open 5’ and 3’ ends in the dumbbell-shaped structures.   
Oligonucleotide 1
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Figure 5-5. Schematic representation of a C3-spacer-containing dumbbell-shaped 
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Figure 5-6.  Diagrammatic illustration of anticipated inhibitory mechanisms of a C3-
spacer-containing oligonucleotide (Oligonucleotide 1) on the activities of human 
topoisomerase I in our studies. When Oligonucleotide 1 is incubated with Topo I 
(Step 1), this nuclear enzyme is expected to bind to the oligonucleotide and 
subsequently form a covalent bond with the newly generated 3’ end of DNA and to 
hold the 5’ end through physical interaction (Structure b). The presence of C3-spacer 
near the newly generated 5’ end will interrupt the integrity of complementarity of the 
local duplex structure, which could consequently allow the trinucleotide of 5’ G-G-A- 
to dissociate freely from its complementary tract (Structure c). This free dissociation 
of 5’ G-G-A- from its complementary sequence could make the religation reaction 
impossible, thus leading an irreversible damage to the enzyme.   
5.2.2 Synthesis and Characterization of C3-Spacer-Containing Circular 
Oligonucleotides  
Synthesis of Oligonucleotide 1 was subsequently carried out in this study 
through enzymatic ligation reaction (Figure 5-7).  The 5’ phosphorylated linear 
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precursor of 86-mer oligonucleotide containing a C3-spacer modification was 
provided by Sigma-Proligo. By using its own duplex backbone as template, the two 
termini were ligated at 15 °C in the presence of T4 DNA ligase. The results were 
analyzed via 15% denaturing PAGE. As shown in Figure 5-8, a band with faster 
mobility shift appeared after 2 hours and the circulization was almost completed in 12 
hours. Circularity of the backbone of the formed Oligonucleotide 1 was further 
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Figure 5-8. Polyacrylamide gel electrophoretic analysis of formation of 
Oligonucleotide 1. 86-mer linear precursor (Olignucleotide L in Table 5-2) with free 
5’-hydroxyl terminus was labeled at its 5’-end with [γ-32P]ATP (Ge-Healthcare) 
catalyzed by T4 polynucleotide kinase (New England Biolabs). A mixture containing 
50 mM Tris (pH 7.5), 10 mM MgCl2, 1mM ATP, 10 mM dithiothreitol, 25 lg/ml BSA, 
and 10 μM 32P-labeled 86-mer linear precursor was then kept at 95°C for 5 min and 
further allowed to cool down to 25°C over 2 h. After the reaction mixture was 
incubated at 4 °C for another 4 h, 10 units of T4 DNA ligase was added, which was 
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further incubated at 15 °C for different time periods. Lane 1: linear precursor 
(Oligonucleotide L) alone, lanes 2–4: ligation reaction of Oligonucleotide L 
catalyzed by T4 DNA ligase lasting for 2, 4, and 12 h, respectively. 
 
T7 exonuclease - + - +





Figure 5-9. Polyacrylamide gel electrophoretic analysis of circularity of 
Oligonucleotide 1 in its backbone. The 32P-labeled reaction products in the lower 
band of Lane 4 (presumably Oligonucleotide 1) in Figure 5-8 were cut off and 
purified. Solutions containing 20 mM Tris-acetate, 50 mM potassium acetate, 10 mM 
Magnesium Acetate, 1 mM Dithiothreitol, 5 units of T7 exonuclease and 32P-labeled 
oligonucleotides were incubated next at 25 °C for 2 h. Lane 1: 32P labeled 5’ 
phosphorylated 86-mer linear precursor (Oligonucleotide L) alone, Lane 2: 32P 
labeled 5’ phosphorylated 86-mer Oligonucleotide L in the presence of T7 
exonuclease, Lane 3: Oligonucleotide 1 (purified from the lower band in lane 4 in 
Figure 5-7) alone, Lane 4: Oligonucleotide 1(purified from the lower band in lane 4 
in Figure 5-7)  in the presence of T7 exonuclease. 
5.2.3 Inhibitory Studies of the Newly Designed Oligonucleotides on the 
Activity of Topoisomerase I Inhibitors  
The inhibitory effect of Oligonucleotide 1 on the activity of human Topo I 
was examined through determining the efficiency of relaxation reaction of pBR322 
catalyzed by this DNA relaxing enzyme in the presence of our newly designed 
dumbbell-shaped oligonucleotides. As shown in Figure 5-10, the ratio of relaxed 
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forms to non-relaxed forms of pBR322 decreased with the increase of concentration 
of Oligonucleotide 1 (Figure 5-10b) and the obtained IC50 value for Oligonucleotide 
1206  was 36.6 nM (Figure 5-11) under our reaction conditions. As a control 
experiment, the inhibitory effect of Oligonucleotide 2 was also examined in our 
studies, which possesses the same sequence as that of Oligonucleotide 1 except for 
the absence of a C3-spacer in its duplex structure. As shown in Figure 5-10c, this 
non-C3-spacer-containing oligonucleotide displayed much low inhibitory efficiency 
and gave rise to an IC50 value as high as ~1.2 μM. The observed difference in 
inhibitory efficiency between Oligonucleotide 1 and Oligonucleotide 2 could be 
taken as an indication that C3-spacer modification indeed plays a crucial role in the 
inhibitory action on the activity of Topo I as originally designed (Figure 5-6).  
supercoiled pBR322 + human Topo I
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Figure 5-10. Agarose gel electrophoretic analysis of inhibitory effect of 
Oligonucleotide 1 (b) and Oligonucleotide 2 (c) on the activities of human 
topoisomerase I. Oligonucleotide 1 or 2 and 1 unit human topoisomerase 1 (Topogen, 
2005H-2) were incubated in a buffer of 10 mM Tris-HCl (pH 7.9), 150 mM NaCl, 
0.1% bovine serum albumin (BSA), 0.1 mM spermidine, and 5% glycerol in a total 
volume of 20 μL at 25 °C for 5 mins. 400 ng pBR322 was following added and the 
new mixtures were further allowed to react at 37 °C for 20 mins. The samples were 
analyzed using agarose gel (1.0%, w/v) eletrophoresis (100V for 1h) followed by 
ethidium bromide staining. The DNA bands were visualized using Gel Documentatoin 
system (G:Box HR, Syngnene, Cambridge, UK) equipped with Gene Tools Software. 
b) Concentrations of Oligonucleotide 1 in lane 2-8 were 0 nM, 500 nM, 250 nM, 50 
nM, 25 nM, 5 nM, 1 nM respectively. Lane 1 is pBR 322 alone. c) Concentrations of 
Oligonucleotide 2 in lane 2-6 were 0 nM, 1 nM, 10 nM, 100 nM, 1000 nM 
respectively. Lane 1 is pBR 322 alone. 
 
 

















Figure 5-11.  Correlations between concentration of Oligonucleotide 1 and percent 
inhibition on topoisomerase I activity. Percentage of relaxation was defined as the 
ratio of band density of relaxed DNA over those of relaxed DNA plus supercoiled 
DNA [relaxed DNA/ (relaxed DNA + supercoil DNA)] while (100%- percentage of 
relaxation) was taken as the percent inhibition of topoisomerase I activity by 
oligonucleotides. The DNA bands were analyzed using Gel Documentation System 
(G:Box HR, Syngnene, Cambridge, UK) equipped with Gene Tools Software. IC50 
value is calculated by GraphPad Prism 4 software.  
 
5.2.4 Confirmation of the Existence of Topoi-DNA Covalent Conjugate 
 In order to verify that some covalent conjugates could be indeed formed 
between Topo I and Oligonucleotide 1 in the inhibitory process shown in Figure 5-
10b as designed, 32P-labeled Oligonucleotide 1 was incubated with Topo I during our 
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investigations and the mixture was analyzed through denaturing polyacrylamide gel 
electrophoresis. As shown in Figure 5-12, with the increase of amount of Topo I from 
4 units to 16 units, new slow moving bands (Band 2) were observed (lane 2 to lane 7). 
Generation of the new bands (Band 2) in these studies could be considered as the sign 
that covalent conjugates between Topo I and Oligonucleotide 1 were formed under 
our reaction conditions as anticipated.  
reaction temperature
32P-labeled Oligonucleotide 1
amount of Topo I
Band 2
Band 1
37 °C room temperature
+
4 U 8 U 16 U 4 U 8 U 16 U
+ + + + +
0 U
+
lane 1              2       3       4      5      6      7
(Band 1 corresponds to 32P-labeled 
Oligonucleotide 1)
(Band 2 presumably corresponds to 
Topo I-32P-labeled  Oligonucleotide 
1 covalent conjugates)
 
Figure 5-12. Denaturing polyacrylamide gel electrophoretic confirmation of 
formation of Topo I-Oligonucleotide 1 covalent conjugates (see Structure c in Figure 
5-6). Solutions (20 μL) containing 32P-labeled Oligonucleotide 1, Topo I, 1X Topo I 
reaction buffer (10 mM Tris-Cl at pH 7.9, 150 mM NaCl, 0.1 % BSA, 0.1 mM 
Spermidine, 5 % glycerol), 10 mM MgCl2, 50 mM KCl were incubated at 37 °C or 
room temperature for 1 h, which were further loaded on denaturing polyacrylamide 
gel [6% PAGE (29:1) containing 7 M urea]. Lane 1: 32P-labeled Oligonucleotide 1 
alone; lane 2 to lane 4: 4 U, 8 U and 16 U Topo I respectively (reaction carried out at 
37 °C), lane 5 to lane 7: 4 U, 8 U and 10 U Topo I respectively (reaction carried out at 
room temperature). 
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5.2.5 Examination of Resistance of Oligonucleotide 1 against Repair 
Enzyme  
 To maintain the integrity of its genome and normal functioning, cell adopts 
intricate enzymatic systems for detecting and resolving DNA damages generated by 
environmental factors and normal metabolic processes.207 A number of DNA repair 
enzymes such as those that recognize mismatch base pairs and nicked sites have been 
identified in the past,. One of our major intentions in placing a C3-spacer into 
Oligonucleotide 1 is to prevent its degradation by DNA repair proteins for taking 
place as neither mismatch base pairs nor nicked sites will be generated upon 
introduction of this modification.208 As model studies, T7 endonuclease I, a DNA 
repair protein that removes mismatch base pairs and nicked sites from duplex DNA 
sequences, was selected during our investigations. This DNA repair protein was 
accordingly allowed to react with a mismatch-containing dumbbell-shaped structure 
(Oligonucleotide 3),198, 208 which was consequently hydrolyzed into low molecular 
weight fragments within 1 hour (lane 4). However, when Oligonucleotide 1 (C3-
spacer-containing dumbbell-shaped structure) and Oligonucleotide 2 (regular 
dumbbell-shaped structure without modification) were incubated with T7 
endonuclease I, no degradation product was generated (lane 6 and lane 2 in Figure 5-
13). These observations indicate that our newly designed C3-spacer-containing 
oligonucleotides could indeed resist DNA repair protein as expected. 
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Figure 5-13. Polyacrylamide gel electrophoretic analysis of hydrolytic products of 
Oligonucleotide 1, 2 and 3 generated by T7 endonuclease I. Solutions containing 50 
mM NaCl, 10 mM Tris-HCl (pH 7.9), 10 mM MgCl2, 1 mM Dithiothreitol, 10 U of 
T7 endonuclease I and 32P-labeled oligonucleotides (Oligonucleotide 1, 2 or 3) were 
incubated at 37 °C for 1 h. The hydrolytic reaction products were further analyzed 
using polyacrylamide gel electrophoresis (15%). Lane 1: 86-mer circular 
Oligonucleotide 2 alone, Lane 2: 86-mer circular Oligonucleotide 2 in the presence 
of T7 endonucleaese I, Lane 3: 86-mer circular Oligonucleotide 3 alone, Lane 4: 86-
mer circular Oligonucleotide 3 in the presence of T7 endonucleaese, Lane 5: 86-mer 
circular Oligonucleotide 1 alone, Lane 6: 86-mer circular Oligonucleotide 3 in the 
presence of T7 endonucleaese I. 
 
5.2.6 Position Dependence of C3-Spacer Modification on the Inhibitory 
Efficiency of Topoisoemrase I 
With the purpose of determining the correlation between position of C3-
spacers in the dumbbell-shaped structures and inhibitory efficiency of human Topo I, 
additional oligonucleotides containing C3-spacers at certain different locations were 
subsequently synthesized (Table 5-2) and examined. As shown in Table 5-1, when a 
C3-spacer appeared near the Topo I-cutting site, the inhibitory efficiencies of the 
corresponding oligonucleotides decreased progressively (IC50 of Oligonucleotide 4 = 
89 nM; IC50 of Oligonucleotide 5 = 52 nM while IC50 of Oligonucleotide 1 = 37 nM). 
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This happened most likely because a C3-spacer, when it occurred near the cutting site 
of Topo I, could disturb the cutting-action of this DNA relaxing enzyme. On the other 
hand, when a C3-spacer emerged far off from Topo I-cutting site, the corresponding 
oligonucleotides displayed low inhibitory efficiency as well (IC50 of Oligonucleotide 
6 = 63 nM; IC50 of Oligonucleotide 7 = 93 nM) as compared to Oligonucleotide 1. 
These decreases of inhibitory efficiency could be caused by that when these C3-
spacers are located far away from the Topo I-cutting site, they will be in a position 
close to the second binding site of Topo I (Figure 5-5), which could consequently 
prevent the binding of this nuclear enzyme to the corresponding oligonucleotides. 
Table 5-1. Inhibitory efficiency (IC50) of some C3-spacer-containing oligonucleotides 
on the activity of human Topo I.[a] 
Names of oligonucleotides IC50 (nM) 
Oligonucleotide 4 (C3-spacer between G+1 to G+2) 89 
Oligonucleotide 5 (C3-spacer between G+2 to A+3) 52 
Oligonucleotide 1 (C3-spacer between A+3 to A+4) 37 
Oligonucleotide 6 (C3-spacer between A+4 to A+5) 63 
Oligonucleotide 7 (C3-spacer between A+5 to A+6) 93 
 [a] See Table.5-2 for detailed sequences of these oligonucleotides. 
Table 5-2. Sequences and C3-spacer modifications of oligonucleotides prepared 
during this study:[b]   
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* C3-spacer is positioned  between A+3 and A+4 
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5.3 Gap-Containing Unimolecular Oligonucleotides as Topoisomerase 
I Inhibitors 
The innate substrates of DNA topoisomerase I in vivo are positive and 
negative supercoiled DNA formed from the processes of replication, transcription, and 
chromatin condensation. It has been demonstrated in the past years, in addition to 
these supercoiled structures, that a few linear duplex oligonucleotides could act as 
substrates of eukaryotic topoisomerase I in vitro.185-189 One of such duplex sequences 
(Duplex 1) that contains topoisomerase I-binding and cutting sites are illustrated in 
Figure 5-14.192-197 Subsequent investigation in this research field demonstrated that 
when a gap was present in the topoisomerase I-binding sequence near its cutting site, 
one strand of the duplex oligonucleotide substrates could generate covalent linkages 
with the enzyme in an irretrievable manner.204-205 These discoveries have given us the 
inspiration to look recently at the possibility of using gap-containing unimolecular 
oligonucleotides as irreversible inhibitors of human topoisomerase I. Here we report 
the results of our examination on the inhibitory effect of certain oligonucleotides on 














3' CTAGATTTTCTGAA CTTTTTAAAAATTTTTTCTAG 5'
Duplex 2 
(Trimolecular)
extremely stable hairpins extremely stable hairpins  
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Figure 5-14.  Sequences of oligonucleotides used in the study of Topoisomerase I 
Inhibitors. The shadowed tracts in Duplex 1 denote the topoisomerase I-binding tracts, 
and the cutting site by topoisomerase I is indicated by .  
 
5.3.1 Design Strategy of Gap-containing Oligonucleotides as 
Topoisomerase I Inhibitors 
A gap-containing unimolecular oligonucleotide Duplex 3 in Figure 5-14 was 
also designed that possessed two “extraordinarily thermostable hairpins”201 at the two 
end of the duplex structure according to our early investigation. These hairpin 
structures could in theory lead to an increase of the thermal stability of Duplex 3. In 
addition, it was anticipated that topoisomerase I could bind to Duplex 3 and further 
cause a scission on one of the two strands at the designed cutting site if topoisomerase 
I and Duplex 3 are allowed to interact with each other. After a nick is generated in 
Duplex 3 by topoisomerase I, a religation reaction between the cut fragments might 
not be able to take place because the presence of a gap near the cutting site could 
cause improper conformational alteration, thus leading to chemically irreversible 
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Figure 5-15. Illustration of possible mechanism for gap-containing oligonucleotides 
as Topoisomerase I Inhibitors. 
 
5.3.2 Examination of Inhibitory Effect of Gap-containing 
Oligonucleotides as Topoisomerase I Inhibitors 
Two different types of tests about the inhibitory effects of Duplex 3 on human 
topoisomerase I were performed during our investigations. Duplex 3 was 
preincubated with topoisomerase I for 3 minutes prior to the addition of plasmid DNA 
in the first types of tests (preincubaton test) while in the second type of tests, 
topoisomerase I, pBR322 and Duplex 3 were mixed together simultaneously (tests 
without preincubation). During the preincubation tests, Duplex 3 was expected to 
have enough time to bind and further generate irreversible linkages with 
topoisomerase I without the inference of pBR322.  As shown in Figure 5-16, 
relaxation of negatively supercoiled pBR322 by topoisomerase I was near completion 
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in the absence of Duplex 3 (Lane 2).  With the addition and increase of concentration 
of Duplex 3, on the other hand, the inhibitory effect of this dumbbell-shaped structure 
on the relaxation reaction of supercoiled pBR322 increases (Lane 3 to Lane 8).  The 
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Figure 5-16.  Agarose gel electrophoretic analysis of inhibitory effect of Duplex 3 on 
human topoisomerase I. Duplex 3 and 1 unit human topoisomerase I were incubated 
in a buffer of 10 mM Tris-HCl (pH 7.5), 100 mM NaCl, 1 mM PMSF and 1.0 mM 
mercaptoethanol in a total volume of  20 μL at 25 °C for 3 min. When this 
preincubation was over, pBR322 was added and the new mixtures were adjusted to 
contain 10 mM Tris-HCl (pH 7.5), 100 mM NaCl, 1 mM PMSF, 1.0 nM 
mercaptoethanol, 400 ng pBR322, 1 unit of human topoisomerase I and different 
concentrations of Duplex 3, which was further allowed to react at 37 °C for 20 mins.  
Concentrations of Duplex 3 in the samples from Lane 3 to Lane 8 were 500 nM, 250 


























Figure 5-17. Correlations between percent inhibition on topoisomerase I activity and 
concentration of Duplex 3. Percentage of relaxation was defined as the ratio of band 
density of relaxed DNA over those of relaxed DNA plus supercoiled DNA [relaxed 
DNA/ (relaxed DNA + supercoil DNA)] while (100%- percentage of relaxation) was 
taken as the percent inhibition of topoisomerase I activity by oligonucleotides. The 
DNA bands were analyzed using Gel Documentation System (G:Box HR, Syngnene, 
Cambridge, UK) equipped with Gene Tools Software.  IC50 value is calculated by 
GraphPad Prism 4 software.  
 
As a comparison test, the inhibitory effect of Duplex 2 was also examined in 
our studies, which contains the same duplex sequence as Duplex 3 does (Figure 5-14).  
Different from Duplex 3, on the other hand, Duplex 2 is a trimolecular complex 
rather than a unimolecular entity and does not possess two “extremely stable hairpins” 
in its structure.  As shown in Figure 5-18, this trimolecular structure exhibited 
inhibitory effect on the relaxation reaction of pBR322 by topoisomerase I as well. The 
IC50 value of Duplex 2 is 568 nM, which is about 8 times greater than the one 
obtained when Duplex 3 was used (72.3 nM).  The difference of IC50 values between 
Duplex 2 and Duplex 3 could be attributed to that the unimolecular structure of 
Duplex 3 has a higher melting point and generates duplex structure more efficiently 
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Figure 5-18.  Agarose gel electrophoretic analysis of inhibitory effect of Duplex 2 on 
human topoisomerase I.  The same procedures as those prepared for the samples in 
Figure 5-16 were used except for replacing Duplex 3 with Duplex 2. Concentrations 
of Duplex 2 in the samples from Lane 3 to Lane 8 were 1000 nM, 500 nM, 250 nM, 
50 nM, 10 nM, and 1 nM respectively. 
 
 
















Figure 5-19. Correlations between percent inhibition on topoisomerase I activity and 
concentration of Duplex 2. IC50 value is calculated by GraphPad Prism 4 software.  
 
Duplex 1 is a 36 mer linear duplex sequence containing topoisomerase I-
binding and cutting sites (Figure 5-14).  Different from Duplex 2 and Duplex 3, this 
duplex structure contains perfectly matched base pairs in its structure.  As control 
experiments, the inhibitory effect of Duplex 1 on the activity of topoisomerase I was 
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examined during our investigation.  As shown in Figure 5-20, this bimolecular 
complex displayed much lesser inhibitory efficiency than Duplex 2 and Duplex 3 do 
and showed an IC50 value of about 1.4 μM.  The lower inhibitory efficiency of 
Duplex 1 could possibly be due to that the perfectly matched sequence of Duplex 1 is 
not capable of forming an irreversible linkage with topoisomerase I during the strand 
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Figure 5-20.  Agarose gel electrophoretic analysis of inhibitory effect of Duplex 1 on 
human topoisomerase I.  The same procedures as those prepared for the samples in 
Figure 5-16 were used except for replacing Duplex 3 with Duplex 1. Concentrations 
of Duplex 1 in the samples from Lane 3 to Lane 7 were 10,000 nM, 5,000 nM, 2,000 


























Figure 5-21. Correlations between percent inhibition on topoisomerase I activity and 
concentration of Duplex 1. IC50 value is calculated by GraphPad Prism 4 software.  
 
 
In order to make comparison with the preincubation studies (Figure 5-16), 
new tests without preincubation were further carried out during our investigations in 
which Duplex 3, topoisomerase I and pBR322 were mixed together simultaneously 
(Figure 5-22).  Under this condition, Duplex 3 displayed an IC50 value of 1.04 μM 
(Figure 5-23), which is relatively high as compared with the one obtained when 
Duplex 2 was preincubated with topoisomerase I for three minutes (IC50= 72.3 nM). 
Competitions between Duplex 3 and pBR322 in their binding to topoisomerase I 
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Figure 5-22.  Agarose gel electrophoretic analysis of inhibitory effect of Duplex 3 on 
human topoisomerase I without preincubation.  A mixture containing 10 mM TRIS 
(pH 7.5), 100 mM NaCl, 400 ng pBR322, 1 units of human topoisomerase I and 
different concentrations of Duplex 3 were prepared and further incubated at 37 °C for 
20 min. Concentration of Duplex 3 in the samples from Lane 3 to Lane 8 were 1000 
nM, 500 nM, 250 nM, 50 nM, 10 nM and 1 nM respectively.  
 
IC50= 1.04 μM
Duplex 3 (without preincubation) 


















Figure 5-23. Correlations between percent inhibition on topoisomerase I activity and 
concentration of Duplex 3 without preincubation. IC50 value is calculated by 







It was demonstrated in our studies that some C3-spacer-containing dumbbell-
shaped oligonucleotides not only exhibited high inhibitory efficiencies on the activity 
of human topoisomerase I (e.g. IC50 = 36.6 nM for Oligonucleotide 1), but also found 
resistant to the hydrolysis by T7 endonuclease I. In addition, gapped unimolecular 
oligonucleotide containing topoisomerase I-binding site displayed an IC50 value of 
72.3 nM, which is efficient than most of the organic inhibitors (e.g. IC50 of 
camptothecin = 700 nM) in its action on topoisomerase I.  
Recent development demonstrated that oligonucleotides can be introducd into 
eukaryotic cells with reduced cytotoxicity, we expect the newly designed dumbbell-
shaped circular oligonucleotides containing internal C3-spacers as well as gapped 
unimolecular oligonucleotide could act as potential DNA-based therapeutical agents 
that target topoisomerase I. It is also our anticipation that the outcomes of these 
studies could have certain implications in the future design of new inhibitors of DNA 




Materials and Methods 
 
6.1 Materials  
6.1.1 Oligonucleotides 
All oligonucleotides used in our studies are purchased from Sigma-Proligo 
(Singapore) which provided custom oligonucleotides synthesis. 
Oligonucleotides are usually supplied as a lyophilized powder that could be 
re-suspended in water and diluted to suitable concentration for reactions. All 
oligonucleotides samples should be stored at - 20°C. 
Common synthetic oligonucleotides are provided with 5’ end hydroxyl group 
which is suitable for 5’ end labeling reactions. Oligonucleotides used for 
concentration controlled circulization reactions in our studies are purchased with 5’ 
end phosphorylated. Oligonucleotides used for DNA topoisomerase I inhibitors 
(Chapter 5) are purchased with C3-spacer modification.  
 
6.1.2 Enzymes 
Enzymes used in our studies are all from commercial sources. 
a) T4 polynucleotide kinase 
T4 polynucleotide kinase used in our studies is purchased from New England  
Biolabs (Cat. No. M0201L, 2500 units per package, 10 units/μL in 10 mM Tris-HCl, 
50 mM KCl, 0.1 µM ATP, 1 mM Dithiothreitol, 0.1 mM EDTA and 50% Glycerol at 
pH 7.4 @ 25°C ). The enzyme should be stored at - 20°C. It is purified from an E. coli 
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strain carrying a cloned of T4 polynucleotide kinase gene. 
 T4 polynucleotide kinase catalyzes the transfer or exchange of phosphate from 
the γ position of ATP to the 5´ -hydroxyl terminus of polynucleotides (double-and 
single-stranded DNA and RNA) and nucleoside 3´-monophosphates. It also catalyzes 
the removal of 3´-phosphoryl groups from 3´-phosphoryl polynucleotides, 
deoxynucleoside 3´-monophosphates and deoxynucleoside 3´-diphosphates. 
 One unit of T4 polynucleotide kinase incorporates 1 nmol of acid-insoluble 
[32P] in a total reaction volume of 50 μl in 30 minutes at 37°C in 1X T4 
Polynucleotide Kinase Reaction Buffer with 66 µM [γ-32P] ATP (5 x 106 cpm/µmol) 
and 0.26 mM 5´-hydroxyl-terminated salmon sperm DNA. The enzyme was supplied 
with 10 X reaction buffer (0.7 M Tris-HCl, pH 7.6, 100 mM MgCl2, 50 mM 
Dithiothreitol).209 
 
b) T4 DNA ligase 
T4 DNA ligase used in our studies is purchased from New England Biolabs 
(Cat. Number: M0202L, 100,000 units per package, 400 units/μL in 10 mM Tris-HCl, 
50 mM KCl, 1 mM DTT, 0.1 mM EDTA and 50% Glycerol, pH 7.4 @ 25°C ). The 
enzyme should be stored at -20 °C.  
T4 DNA ligases catalyze the formation of a phosphodiester bond between 
juxtaposed 5' phosphate and 3' hydroxyl termini in duplex DNA or RNA. This 
enzyme will join blunt end and cohesive end termini as well as repair single stranded 
nicks in duplex DNA, RNA or DNA/RNA hybrids.  
One unit of T4 DNA ligase gives 50% ligation of HindIII fragments of λ DNA 
(5´ DNA termini concentration of 0.12 µM, 300 µg/ml) in a total reaction volume of 
20 μl in 30 minutes at 16°C in 1X T4 DNA Ligase Reaction Buffer. The enzyme can 
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also catalyze the ligation at room temperature. For cohesive ends, use 1 µl of T4 DNA 
Ligase in a 20 µl reaction for 10 minutes. For blunt ends, use 1 µl of T4 DNA Ligase 
in a 20 µl reaction for 2 hours or 1 µl high concentration T4 DNA Ligase for 10 
minutes. The enzyme was supplied with 10 X reaction buffer (0.5 M Tris-HCl, 100 
mM MgCl2, 10 mM ATP, 100 mM Dithiothreitol, pH 7.5 @ 25°C).210 
 
c) Exonuclease I 
Exonuclease I used in our studies is purchased from New England Biolabs 
(Cat. Number: M0293L, 15,000 units per package, 20 units/µL in 10 mM Tris-HCl, 
100 mM NaCl, 5 mM 2-Mercaptoethanol, 0.5 mM EDTA, 100 µg/ml BSA and 
50% Glycerol, pH 7.5 @ 25°C). The enzyme should be stored at -20°C.  
Exonuclease I was purified from an E. coli strain that carries the cloned Exo I 
gene from E. coli NM554. It catalyzes the removal of nucleotides from single-
stranded DNA in the 3' to 5' direction and degrades excess single-stranded primer 
oligonucleotides from a reaction mixture containing double-stranded extension 
products.  
One unit is defined as the amount of enzyme that will catalyze the release of 
10 nmol of acid-soluble nucleotide in a total reaction volume of 50 μl in 30 minutes at 
37°C in 1X Exonuclease I Reaction Buffer with 0.17 mg/ml single-stranded [3H]-
DNA. The enzyme was supplied with 10 X reaction buffer (670 mM Glycine-KOH, 
67 mM MgCl2, and 100 mM 2-Mercaptoethanol, pH 9.5 @ 25°C).211 
 
d) Exonuclease VII   
Exonuclease VII used in our studies is purchased from GE-Healthcare (Cat. 
Number: 70082Y, 200 units per package, 10 units/µL in  50 mM Tris-HCl, pH 8.0, 
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200 mM NaCl, 0.1 mM EDTA, 10 mM DTT and 50% glycerol.). The enzyme should 
be stored at -20°C.  
 Exonuclease VII is purified from E. coli strain containing overproducing 
clones encoding both the large (xseA) and small (xseB) subunits of Exonuclease VII. 
A strict single-strand directed enzyme with 5' to 3' and 3' to 5'- exonuclease activities 
making it the only bi-directional E. coli exonuclease with single-strand specificity. 
One unit catalyzes the release of 1 nmol of acid-soluble nucleotide in 30 min at 37°C 
under standard conditions.212 
  
e) DNase I 
DNase I used in our studies is purchased from New England Biolabs (Cat. 
Number: M0303L, 5,000 units per package, 2 units/µL in 10 mM Tris-HCl, 
2 mM CaCl2, and 50% Glycerol, pH 7.6 @ 25°C). The enzyme should be stored at -
20 °C.  
DNase I is an endonuclease that nonspecifically cleaves DNA to release di-, 
tri- and oligonucleotides products with 5´ -phosphorylated and 3´ -hydroxylated ends. 
DNase I acts on single- and double-stranded DNA, chromatin and RNA: DNA 
hybrids. 
One unit is defined as the amount of enzyme which will completely degrade 1 
µg of pBR322 DNA in 10 minutes at 37 °C in DNase I Reaction Buffer. Complete 
degradation is defined as the reduction of the majority of DNA fragments to 
tetranucleotides or smaller. The enzyme was supplied with 10 X reaction buffer 




f) T7 endonuclease I (repair protein) 
T7 Endonuclease I used in our studies is purchased from New England 
Biolabs (Cat. Number: M0302L, 1,250 units per package, 10 units/µL in 20 mM Tris-
HCl, 200 mM NaCl, 1 mM Dithiothreitol, 0.1 mM EDTA, 50% Glycerol and 
0.15% Triton X-100, pH 7.5 @ 25°C). The enzyme should be stored at -20 °C.  
T7 Endonuclease I recognizes and cleaves non-perfectly matched DNA, 
cruciform DNA structures, Holliday structures or junctions, heteroduplex DNA and 
more slowly, nicked double-stranded DNA. The cleavage site is at first, second or 
third phosphodiester bond that is 5´ to the mismatch. The protein is the product of T7 
gene 3. 
One unit is defined as the amount of enzyme required to convert > 90% of 1 
µg of supercoiled cruciform pUC(AT) to > 90% linear form in a total reaction volume 
of 50 µl in 1 hour at 37°C. The enzyme was supplied with 10 X reaction buffer 
(100 mM Tris-HCl, 500 mM NaCl, 100 mM MgCl2, and 1 0mM Dithiothreitol, pH 
7.9 @ 25°C).214 
 
g) T7 Exonuclease 
 T7 Exonuclease used in our studies is purchased from New England Biolabs 
(Cat. Number: M0263L, 5,000 units per package, 10 units/µL in 10 mM Tris-HCl, 
5 mM Dithiothreitol, 0.1 mM EDTA and 50% Glycerol,  pH 8.0 @ 25°C). The 
enzyme should be stored at -20 °C.  
T7 Exonuclease is purified from an E. coli strain containing a TYB12 intein 
fusion. It acts in the 5' to 3' direction, catalyzing the removal of 5' mononucleotides 
from duplex DNA. T7 Exonuclease is able to initiate removal of nucleotides from the 
5' termini or at gaps and nicks of double-stranded DNA.216 It will degrade both 5' 
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phosphorylated or 5' dephosphorylated DNA. It has also been reported to degrade 
RNA and DNA from RNA/DNA hybrids in the 5' to 3' direction but is unable to 
degrade either double-stranded or single-stranded RNA. The protein is the product of 
T7 gene 6.217 
One unit is defined as the amount of enzyme required to produce 1 nmol of 
acid-soluble deoxyribonucleotide from double-stranded DNA in a total reaction 
volume of 50 μl in 30 minutes at 25°C in 1X Reaction buffer with 0.15 mM sonicated 
duplex [3H]-DNA. The enzyme was supplied with 10 X reaction buffer (200 mM Tris-
acetate, 500 mM potassium acetate, 100 mM Magnesium Acetate and 
10 mM Dithiothreitol).215 
 
h) Mse I (restriction endonuclease) 
Mse I is a unique restriction endonuclease purifed from E. coli strain that 
carries the MseI gene from Micrococcus species. It recognizes the double stranded 
sequence 5’ TTAA 3’ and cleaves between the two T residues.219 
 
Mse I used in our studies is purchased from New England Biolabs (Cat. 
Number: R0525L, 2,500 units per package, 10 units/µL in 10 mM Tris-HCl 
50 mM NaCl, 1 mM Dithiothreitol, 0.1 mM EDTA, 200 µg/ml BSA and 
50% Glycerol, pH 7.4 @ 25°C). The enzyme should be stored at -20 °C.  
One unit is defined as the amount of enzyme required to digest 1 µg of λ DNA 
in 1 hour at 37°C in a total reaction volume of 50 µl.  The enzyme was supplied with 
10 X reaction buffer (100 mM Tris-HCl, 500 mM NaCl, 100 mM MgCl2, and 
10 mM Dithiothreitol).218 
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i) Recombinant Human Topoisomerase I (wild type protein) 
Recombinant Human Topoisomerase I used in our studies is purchased from 
Topogen (Catalog No. 2005H-RC1, 500 units per package, 8 units /µL in 20mM 
NaH2PO4 at pH 7.4, 300mM NaCl and 500mM Imidazole). The enzyme could be 
stored at 4 °C.  
Topoisomerase I has been overexpressed in baculovirus and affinity purified 
as a single band on SDS-PAGE of 100kDa. The final preparation of enzyme is highly 
active in relaxation of plasmid DNA.  One unit of Topoisomerase I can relax 0.25 μg 
(250 ng) of supercoiled plasmid DNA in 30 min at 37 °C. Relaxation assays were 
carried out in a final volume of 25 μl in Topisomerase I reaction buffer (10X reaction 
buffer): 100 mM Tris-Cl at pH 7.9, 1.5 M NaCl, 1 % BSA, 1 mM Spermidine, 50 % 
glycerol.220 
 
6.1.3 pBR322 DNA 
pBR322 used in our studies is purchased from New England Biolabs (Cat. 
Number: N3033L, 1,000 μg /ml in 10 mM Tris-HCl, 1 mM EDTA, pH 8.0 @ 25°C). 
This plasmid DNA vendor should be stored at -20°C. 
pBR322 DNA is isolated from E. coli ER2272 by a standard plasmid 
purification procedure. It is a commonly used plasmid cloning vector in E. coli. 222 
The molecule is a double-stranded circle 4,361 base pairs in length. 223 pBR322 
contains the genes for resistance to ampicillin and tetracycline, and can be amplified 






a) TBE buffer 
TBE buffer used in our studies are purchased from 1st Base Pte Ltd. 
(Cat.Number: 3010-10 X 1L, 1L per package). It is supplied in 10 times concentration 
solution which contains 1M Tris, Borate Acid and EDTA (pH 8.3). 
 
b) TAE buffer 
TAE buffer used in our studies are purchased from 1st Base Pte Ltd. 
(Cat.Number: 3000-10 X 1L, 1L per package). It is supplied in 10 times concentration 
solution which contains 1M Tris, Acetate Acid and EDTA (pH 8.0). 
 
c) Tris-HCl 
Tris-HCl buffer used in our studies are purchased from 1st Base Pte Ltd. 
(Cat.Number: 1415 -1L, 1L per package, contains 1M Tris (pH 7.0). 
 
d) MES 
MES used in our studies are purchased from Sigma-Aldrich (Cat. Number: 
M3671-50G) in solid state. It was dissolved in deionized water at desired 
concentration and adjusted to appropriate pH value by using 1M NaOH or 1M HCl. 
 
e) HEPES 
HEPES used in our studies are purchased from Sigma-Aldrich (Cat. Number: 
H3375-25G) in solid state. It was dissolved in deionized water at desired 




6.2.1 5’ End labeling of DNA (T4 Polynucleotide Kinase method) 
End labeling is a rapid and sensitive method in visualizing small amount of 
DNA. it includes 3’ End labeling and 5’ end labeling which introducing labeling 
groups onto 3’ or 5’ end of target sequences via enzyme catalytic reaction respectively. 
Compare to the rapidly developed nonradioactive method, radioactive labeling is still 
our first choince because 1) High sensitivity, the radioactive method enable only 
several molecules be detected, it always thousands time or more sensitive than 
nonradioactive methods; 2) the radioactive atom used in end labeling possessing same 
chemical and physical properties as their non-radioactive isotopes. 32P 5’ end labeling 
provides us a possibility to study the oligpdeoxyribonucleotide in its native properties, 
especially in the ligation reaction of the 3’ and 5’ end together forming a normal 
phosphate bond.224 
Polynucleotide kinase was commonly used in 5’ end labeling of single strand 
oligonucleotides. The standard reaction was conducted as following described:  
5’ hycroxyl oligonucleotide (100 μM) 2 μL 
10 X reaction buffer 2 μL 
T4 PNK ( 10 units/ μL) 1 μL 
[γ-32P] ddATP (10 μCi/ μL ) 2 μL 
H2O 13 2 μL 
10 X reaction buffer including: 0.7 M Tris-HCl, pH 7.6, 100 mM MgCl, 50 mM 
Dithiothreitol. 
The reaction mixture was incubated at 37 °C for 1 hour. 10 μL denaturing 
loading buffer was added before loading on a 20% (19:1) denature PAGE for further 
purification.  
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6.2.2 Polyacrylamide Gel Electrophoresis (PAGE) 
Two types of polyacrylamide gels are in common use: One is nondenaturing 
polyacrylamide gel for the separation and purification of fragments of double-
stranded DNA or other type secondary structure of DNA. The other is denaturing 
polyacrylamide gel for the separation and purification of single-stranded fragments of 
oligonucleotides. Preparations of denaturing and nondenaturing gels are similar.  
Acrylamide stock solution (20% (19:1), 7M Urea). 224 
Acrylamide 190 g 
N,N’-methylenebisacrylamide 10 g 
10 X TBE buffer  100 mL 
Urea 420 g 
H2O To 1 L 
10% Ammonium oersulfate solution was prepared via dissolving 1 g Ammonisum 
persulfate in 10 mL H2O. The solution may be stored at 4 °C for several weeks. 
 Place the required quantity of acrylamide solution in a clean beaker. Add 30 
μL of TEMED (N,N,N’,N’-tetramethylethylenediamine) to acrylamide solution, then 
500 μL 10% (w/v) ammonium persulfate water solution. Mix the solution by stirring. 
Pour into the gel plate. The gel will be solidified in 15 mins.  
 
6.2.3 DNA Purification (Desalting) 
Oligonucleotides eluted from gel or produced in reactions are solved in buffers. 
Purifications of oligonucleotides are needed in most cases. Many methodologies have 
been developed to fulfill this purpose, such as dialysis, ion-exchange and solid phase 
extraction.  
a) Solid phase extraction.  
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The common used is Waters Sep-Pak 1 mL (100 mg) C18 Cartridge 
(WAT023590). All solvents were applied to cartridge in a rush through method. New 
cartridge was activated by 500 μL CH3CN for two times, washed by 500 μL H2O for 3 
times and loaded with 500 μL 1M Tris-HCl pH 7.0 buffer. The oligonucleotides 
solution was subsequently pushed through slowly at about 500 μL per minute. 
Cartridge containing sample was then washed with 500 μL water for 3-5 times. 
Purified oligonucleotides were eluted from column by 500 μL CH3CN/H2O (1:1 v/v). 
Fraction containing oligonucleotides was collected drop by drop and dried in SpinVac.  
 
b) Ion-exchange purification 
To purify the radio-labeled probes, the common used column is NAP-25 
columns from GE Healthcare. The columns are pre-packed with Sephadex G-25 DNA 
Grade in distilled water (which contains 0.15% Kathon CG/ICP Biocide, used as a 
preservative) and can be stored at room temperature. They come in different sizes for 
purifying different volumes of samples: 0.5 ml (NAP-5), 1 ml (NAP-10), and 2.5 ml 
(NAP-25). 
NAP columns are designed for the rapid and efficient desalting, buffer 
exchange and purification of DNA and oligonucleotides (equal or greater than 10 
mers) utilizing gravity flow. The gel bed dimensions are 1.5 x 4.9 cm, the maximum 
sample volume is 2.5 ml, and the volume of eluted sample is 3.5 ml. The columns 
must be equilibrated with 25 ml 10 mM sodium phosphate buffer (pH 6.8), Once 
equilibrated, the probe is added in 2.5 ml and additional 3.5 ml of equilibration buffer 









+ C NBr C N
Dry Benzene
 
A solution of 0.05 moles BrCN (Sigma-Aldrich, Cat. Number: 16774) in 25 
ml dried benzene (Sigma-Aldrich, Cat. Number: 319953) was added dropwisely with 
stirring to a solution of 0.05 moles imidazole (Sigma-Aldrich, Cat. Number: I0125) in 
50 mL dried benzene under 50 °C. After addition, the mixture was stirred at 50 °C for 
another 5 mins, and then cooled to 4 °C. The reaction was kept at 4 °C for 24 hours 
and the bright yellow solid was removed by filtration. A clear, colorless filtration was 
concentrated to dryness via rotary evaporator. The product, white crystalline solid was 
purified by sublimation.  Yielding about 10% needle like colorless crystal and stored 
at -20°C in dark.225 
 
6.2.5 Chemical ligation reactions of unimolecular G-quadruplex 
using N-cyanoimidazole (Chapter 4)  
A stock solution of Sequence 1 in 100 mM MES (pH 6.0) and 100 mM KCl 
were kept at 100 °C for 3 min followed by cooling the mixture to 25 °C over a period 
of 120 min to allow the formation of unimolecular G-quadruplexes.  The reaction 
mixtures consisting of 1 μM of Sequence 1 taken from the stock solution, 100 mM 
MES (pH 6.0), 100 mM KCl, 10 mM MnCl2 and 10 mM N-cyanoimidazole in a total 
volume of 20 μL were then prepared and incubated at 25 °C for 6 h.  The reaction was 
next terminated by the addition of loading buffer and the resultant ligation product 
was analyzed by polyacrylamide gel electrophoresis. 
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6.2.6 Self-cleavage reactions of Oligonucleotide 1 (Chapter 3) 
All cleavable oligonucleotides were incubated at 20 °C in a buffer solution of 
5mM HEPES (pH 7.0) and in the presence of 5 mM KCl for 2 h in order to allow the 
formation of proper G-quadruplex assemblies. The self-cleavage reactions of 
Oligonucleotide 1 were initiated by adding MgCl2 to the reaction mixture, which was 
then kept at 30 °C for an additional 2 h to allow the site-specific self-cleavage. 
 
6.2.7 Fluorescence measurement (Chapter 2) 
Fluorescence measurements were done on a Perkin-Elmer LS55 fluoremeter. 
All the emission spectra were taken by excitation at 480nm, which is the absorption 
maximum of Bodipy 493/503. All the measurements were done in 10 mM 
MES/HEPES buffer solutions with variation of pH value and data were recorded at 20 
°C. 
 
6.2.8 Thermal Stability Analysis of Oligonucleotides by UV 
spectroscopy (Chapter 2) 
4 uM oligonucleotide were prepared in 10 mM Tris-HCl (pH 7.9) and 50 mM 
NaCl of total volume of 400 μL for its thermal stability analysis. The melting points 
of the oligonucleotides were determined by measuring the absorbance of the 
oligonucleotides at 260 nm by an UV spectrophotometer (Nicolet Evolution 3000, 
Thermo Electron Corporation) equipped with a thermoelectric cell holder. The rate of 
temperature increase was adjusted to 0.5 °C / min. The melting points of the 
oligonucleotides were determined by the inflection point on its melting point curves. 
 
6.2.9 CD measurement (Chapter 3 & 4) 
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The samples were dissolved in 10 mM Tris-HCl buffer solution, various 
concentrations of metal ions and allowed to equilibrate overnight. CD spectra were 
recorded on a Jasco J-810 spectropolarimeter in a 1mm pathlengh cuvette.  The 
wavelength scans were done at room temperature with a scan rate of 100nm/min. For 
thermal denaturation experiments, the temperature was changed from 20 °C to 90 °C 
at a rate of 2 °C/min and the CD at 295 nm was monitored. 
6.2.10 Empirical estimation of duplex Melting temperature  
Melting temperature (Tm) is the temperature at which an oligonucleotide 
duplex is 50% in single-stranded form and 50% in double-stranded form. The 
empirical estimation of TM based on the nearest-neighbor two-state model, which is 
applicable to short DNA duplexes.  
Tm (°C) =
S° + R ln[oligo]
H°
   273.15
 
where H° (enthalpy) and S° (entropy) are the melting parameters calculated 
from the sequence and the published nearest neighbor thermodynamic parameters, R 
is the ideal gas constant (1.987 cal K-1mole-1), [oligo] is the molar concentration of an 
oligonucleotide, and the constant of - 273.15 converts temperature from Kelvin to 
degrees of Celsius.  





















TM depends on monovalent salt concentration ([Na+]) of the solvent. The 
improved quadratic TM salt correction function was reported by Owczarzy, R. et al. 






+ 4.29 f(GC)-3.95) X 10-5 ln[Na+] + 9.40 X 10-6 ln2 [Na+]
 
* where f(GC) is the fraction of GC base pairs.  
6.2.11 General procure for Exonuclease VII hydrolysis (Chapter 4)  
The identified circular product with a slower rate of mobility shift (Lane 9, 
Figure 7) was purified through polyacrylamide gel electrophoresis.  A reaction 
mixture containing 1×exonuclease VII buffer (100 mM Tris-HCl, 100 mM potassium 
phosphate, 16.6 mM ethylenediamine tetraacetic acid and 20 mM 2-mercaptoethanol, 
pH 7.9), 20 units of exonuclease VII  and the identified circular product or Sequence 
1 in a total volume of 20 μL was subsequently prepared and incubated at 37 °C for 2 h.  
This reaction product was next analyzed through polyacrylamide gel electrophoresis.  
 
6.2.12 Partial hydrolysis of the identified circular product by DNAse 
I   (Chapter 4)  
A reaction mixture containing 1 x DNAse I buffer (100 mM sodium acetate and 5 mM 
magnesium sulfate, pH 5.0 ), 10 units DNAse I and the identified circular product in a total 
volume of 20 μL was incubated at room temperature for 30 min.  This hydrolysis reaction was 
terminated by freezing the samples in liquid nitrogen and the reaction product was analyzed 
through polyacrylamide gel electrophoresis.  
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